NDC properties for "dexamethasone 0.1 % / tobramycin 0.3 % Ophthalmic Suspension" (RxCUI 309683)
About this data
The tables show NDC propoerties for dexamethasone 0.1 % / tobramycin 0.3 % Ophthalmic Suspension with the RxCUI 309683
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for dexamethasone 0.1 % / tobramycin 0.3 % Ophthalmic Suspension (RxCUI 309683)
| ANDA | ANDA064134 |
|---|---|
| ANDA | ANDA212715 |
| ANDA | ANDA212991 |
| MMSL_CODE | BD3428 |
| MMSL_CODE | CD3428 |
| NDA | NDA050592 |
| RxCUI | 309683 |
| SNOMEDCT | 1231528002 |
| SNOMEDCT | 134748003 |
| SPL_SET_ID | 05fd0c36-39b4-4a43-8490-eb8dfc0920ae |
| SPL_SET_ID | 09315f0b-f15a-30d5-e063-6394a90ac8dd |
| SPL_SET_ID | 0e460787-5413-44d3-bd60-69d3d04f97eb |
| SPL_SET_ID | 11c2ba9a-7aa3-4f78-aa2f-2a35d2671681 |
| SPL_SET_ID | 1884ef6f-a60c-4a82-a7dc-fd48b7176db0 |
| SPL_SET_ID | 238bec79-88cf-ae9f-e063-6394a90aaf1c |
| SPL_SET_ID | 2a7eea7d-b82d-481a-a83d-96fe21d21cd2 |
| SPL_SET_ID | 33de419e-a89b-47e5-952b-87e837f5d531 |
| SPL_SET_ID | 3c63c481-ce57-41ca-993f-5a5b665fa1e4 |
| SPL_SET_ID | 5dda7621-5438-4522-8be0-bc2e8dc418c5 |
| SPL_SET_ID | 61693e79-81d1-3162-e053-2a91aa0ae925 |
| SPL_SET_ID | 7e34b1a9-8d21-41db-9070-37227975414f |
| SPL_SET_ID | 8d6a8a22-fd97-43e7-a89c-b1f32710a773 |
| SPL_SET_ID | 8f7f1b78-8ac3-4ba5-b0ec-ca87a433ad39 |
| SPL_SET_ID | a562bb1c-89b7-465c-a123-e7e3d5417a4a |
| SPL_SET_ID | a5f0b05b-3dec-4fe8-8106-e41e668a512d |
| SPL_SET_ID | b7b39ad5-e158-b8fe-e053-2995a90a5279 |
| SPL_SET_ID | c33e84ba-4c0c-f738-e053-2995a90aa20a |
| SPL_SET_ID | c606945c-4ffc-4ee8-af04-a00de8ea9259 |
| SPL_SET_ID | cdd9086d-821f-4ac8-bc49-f1869dffb150 |
| SPL_SET_ID | df4a7747-8dfa-4933-b4d2-a3d85c5f74f8 |
| SPL_SET_ID | e236d98c-128e-b2f7-e053-2a95a90a7422 |
| SPL_SET_ID | e4ddce2f-1b91-46e1-a8f0-a38394d4e672 |
| SPL_SET_ID | f4c00d9c-3a17-06a0-e053-2a95a90a8413 |
| VUID | 4009096 |
| Prescribable Synonym | tobramycin 0.3 % / dexAMETHasone 0.1 % Ophthalmic Suspension |
| RXNAV_STR | dexAMETHasone 1 MG/ML / tobramycin 3 MG/ML Ophthalmic Suspension |
| RxNorm Name | dexamethasone 1 MG/ML / tobramycin 3 MG/ML Ophthalmic Suspension |
| RxNorm Synonym | dexamethasone 0.1 % / tobramycin 0.3 % Ophthalmic Suspension |
| Tallman Synonym | dexAMETHasone 0.1 % / tobramycin 0.3 % Ophthalmic Suspension |
| Tallman Synonym | dexAMETHasone 1 MG/ML / tobramycin 3 MG/ML Ophthalmic Suspension |
| Related queries | Interactions (for RxCUI 309683) |
NDC Properties
NDC Item 00574403105
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-05 |
| NDC Item | 00574403105 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (0574-4031-05) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403110
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-10 |
| NDC Item | 00574403110 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (0574-4031-10) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403125
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-25 |
| NDC Item | 00574403125 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (0574-4031-25) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 24208029505
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-05 |
| NDC Item | 24208029505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029510
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-10 |
| NDC Item | 24208029510 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-10) / 10 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029525
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-25 |
| NDC Item | 24208029525 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-25) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 50090113500
| NDC 9 | 50090-1135 |
|---|---|
| NDC 10 | 50090-1135-0 |
| NDC Item | 50090113500 |
| Packaging | 2.5 mL in 1 BOTTLE (50090-1135-0) |
| FDA SPL set id | 718677 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1135 |
NDC Item 50090113600
| NDC 9 | 50090-1136 |
|---|---|
| NDC 10 | 50090-1136-0 |
| NDC Item | 50090113600 |
| Packaging | 5 mL in 1 BOTTLE (50090-1136-0) |
| FDA SPL set id | 803024 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1136 |
NDC Item 50090189300
| NDC 9 | 50090-1893 |
|---|---|
| NDC 10 | 50090-1893-0 |
| NDC Item | 50090189300 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1893-0) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 771442 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1893 |
NDC Item 50090191400
| NDC 9 | 50090-1914 |
|---|---|
| NDC 10 | 50090-1914-0 |
| NDC Item | 50090191400 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1914-0) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 693387 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1914 |
NDC Item 50090726700
| NDC 9 | 50090-7267 |
|---|---|
| NDC 10 | 50090-7267-0 |
| NDC Item | 50090726700 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (50090-7267-0) |
| ANDA | ANDA212715 |
| FDA SPL set id | 817223 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-7267 |
NDC Item 52959098401
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-01 |
| NDC Item | 52959098401 |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 52959098410
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-10 |
| NDC Item | 52959098410 |
| Packaging | 10 mL in 1 BOTTLE (52959-984-10) |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 55700091505
| NDC 9 | 55700-915 |
|---|---|
| NDC 10 | 55700-915-05 |
| NDC Item | 55700091505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (55700-915-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 653524 |
| Labeler | Quality Care Products, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55700-915 |
NDC Item 61314064705
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-05 |
| NDC Item | 61314064705 |
| Packaging | 5 mL in 1 BOTTLE (61314-647-05) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064710
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-10 |
| NDC Item | 61314064710 |
| Packaging | 10 mL in 1 BOTTLE (61314-647-10) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064725
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-25 |
| NDC Item | 61314064725 |
| Packaging | 2.5 mL in 1 BOTTLE (61314-647-25) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 63629957001
| NDC 9 | 63629-9570 |
|---|---|
| NDC 10 | 63629-9570-1 |
| NDC Item | 63629957001 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (63629-9570-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763323 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9570 |
NDC Item 63629957101
| NDC 9 | 63629-9571 |
|---|---|
| NDC 10 | 63629-9571-1 |
| NDC Item | 63629957101 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (63629-9571-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763569 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9571 |
NDC Item 63629957201
| NDC 9 | 63629-9572 |
|---|---|
| NDC 10 | 63629-9572-1 |
| NDC Item | 63629957201 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (63629-9572-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763269 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9572 |
NDC Item 67296066501
| NDC 9 | 67296-0665 |
|---|---|
| NDC 10 | 67296-0665-1 |
| NDC Item | 67296066501 |
| Packaging | 5 mL in 1 BOTTLE (67296-0665-1) |
| FDA SPL set id | 813479 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 67296-0665 |
NDC Item 68071182102
| NDC 9 | 68071-1821 |
|---|---|
| NDC 10 | 68071-1821-2 |
| NDC Item | 68071182102 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (68071-1821-2) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 858986 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-1821 |
NDC Item 68071420305
| NDC 9 | 68071-4203 |
|---|---|
| NDC 10 | 68071-4203-5 |
| NDC Item | 68071420305 |
| Packaging | 5 mL in 1 BOX (68071-4203-5) |
| ANDA | ANDA064134 |
| FDA SPL set id | 790175 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-4203 |
NDC Item 69238137302
| NDC 9 | 69238-1373 |
|---|---|
| NDC 10 | 69238-1373-2 |
| NDC Item | 69238137302 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1373-2) / 2.5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1373 |
NDC Item 69238137403
| NDC 9 | 69238-1374 |
|---|---|
| NDC 10 | 69238-1374-3 |
| NDC Item | 69238137403 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1374-3) / 5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1374 |
NDC Item 69238137506
| NDC 9 | 69238-1375 |
|---|---|
| NDC 10 | 69238-1375-6 |
| NDC Item | 69238137506 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1375-6) / 10 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1375 |
NDC Item 70518399400
| NDC 9 | 70518-3994 |
|---|---|
| NDC 10 | 70518-3994-0 |
| NDC Item | 70518399400 |
| Packaging | 5 mL in 1 BOTTLE (70518-3994-0) |
| FDA SPL set id | 766955 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2024-01-24 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 70518-3994 |
NDC Item 72162112802
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-2 |
| NDC Item | 72162112802 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (72162-1128-2) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112804
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-4 |
| NDC Item | 72162112804 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (72162-1128-4) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112807
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-7 |
| NDC Item | 72162112807 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (72162-1128-7) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 80425026001
| NDC 9 | 80425-0260 |
|---|---|
| NDC 10 | 80425-0260-1 |
| NDC Item | 80425026001 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (80425-0260-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 848958 |
| Labeler | Advanced Rx Pharmacy of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 80425-0260 |
NDC Item 80425036601
| NDC 9 | 80425-0366 |
|---|---|
| NDC 10 | 80425-0366-1 |
| NDC Item | 80425036601 |
| Packaging | 5 mL in 1 BOTTLE (80425-0366-1) |
| FDA SPL set id | 847557 |
| Labeler | Advanced Rx of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2023-11-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 80425-0366 |
NDC Item 00574403105
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-05 |
| NDC Item | 00574403105 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (0574-4031-05) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403110
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-10 |
| NDC Item | 00574403110 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (0574-4031-10) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403125
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-25 |
| NDC Item | 00574403125 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (0574-4031-25) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 24208029505
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-05 |
| NDC Item | 24208029505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029510
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-10 |
| NDC Item | 24208029510 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-10) / 10 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029525
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-25 |
| NDC Item | 24208029525 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-25) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 50090113500
| NDC 9 | 50090-1135 |
|---|---|
| NDC 10 | 50090-1135-0 |
| NDC Item | 50090113500 |
| Packaging | 2.5 mL in 1 BOTTLE (50090-1135-0) |
| FDA SPL set id | 718677 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1135 |
NDC Item 50090113600
| NDC 9 | 50090-1136 |
|---|---|
| NDC 10 | 50090-1136-0 |
| NDC Item | 50090113600 |
| Packaging | 5 mL in 1 BOTTLE (50090-1136-0) |
| FDA SPL set id | 803024 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1136 |
NDC Item 50090189300
| NDC 9 | 50090-1893 |
|---|---|
| NDC 10 | 50090-1893-0 |
| NDC Item | 50090189300 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1893-0) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 771442 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1893 |
NDC Item 50090191400
| NDC 9 | 50090-1914 |
|---|---|
| NDC 10 | 50090-1914-0 |
| NDC Item | 50090191400 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1914-0) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 693387 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1914 |
NDC Item 50090726700
| NDC 9 | 50090-7267 |
|---|---|
| NDC 10 | 50090-7267-0 |
| NDC Item | 50090726700 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (50090-7267-0) |
| ANDA | ANDA212715 |
| FDA SPL set id | 817223 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-7267 |
NDC Item 52959098401
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-01 |
| NDC Item | 52959098401 |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 52959098410
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-10 |
| NDC Item | 52959098410 |
| Packaging | 10 mL in 1 BOTTLE (52959-984-10) |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 55700091505
| NDC 9 | 55700-915 |
|---|---|
| NDC 10 | 55700-915-05 |
| NDC Item | 55700091505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (55700-915-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 653524 |
| Labeler | Quality Care Products, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55700-915 |
NDC Item 61314064705
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-05 |
| NDC Item | 61314064705 |
| Packaging | 5 mL in 1 BOTTLE (61314-647-05) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064710
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-10 |
| NDC Item | 61314064710 |
| Packaging | 10 mL in 1 BOTTLE (61314-647-10) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064725
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-25 |
| NDC Item | 61314064725 |
| Packaging | 2.5 mL in 1 BOTTLE (61314-647-25) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 63629957001
| NDC 9 | 63629-9570 |
|---|---|
| NDC 10 | 63629-9570-1 |
| NDC Item | 63629957001 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (63629-9570-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763323 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9570 |
NDC Item 63629957101
| NDC 9 | 63629-9571 |
|---|---|
| NDC 10 | 63629-9571-1 |
| NDC Item | 63629957101 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (63629-9571-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763569 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9571 |
NDC Item 63629957201
| NDC 9 | 63629-9572 |
|---|---|
| NDC 10 | 63629-9572-1 |
| NDC Item | 63629957201 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (63629-9572-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763269 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9572 |
NDC Item 67296066501
| NDC 9 | 67296-0665 |
|---|---|
| NDC 10 | 67296-0665-1 |
| NDC Item | 67296066501 |
| Packaging | 5 mL in 1 BOTTLE (67296-0665-1) |
| FDA SPL set id | 813479 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 67296-0665 |
NDC Item 68071182102
| NDC 9 | 68071-1821 |
|---|---|
| NDC 10 | 68071-1821-2 |
| NDC Item | 68071182102 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (68071-1821-2) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 858986 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-1821 |
NDC Item 68071420305
| NDC 9 | 68071-4203 |
|---|---|
| NDC 10 | 68071-4203-5 |
| NDC Item | 68071420305 |
| Packaging | 5 mL in 1 BOX (68071-4203-5) |
| ANDA | ANDA064134 |
| FDA SPL set id | 790175 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-4203 |
NDC Item 69238137302
| NDC 9 | 69238-1373 |
|---|---|
| NDC 10 | 69238-1373-2 |
| NDC Item | 69238137302 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1373-2) / 2.5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1373 |
NDC Item 69238137403
| NDC 9 | 69238-1374 |
|---|---|
| NDC 10 | 69238-1374-3 |
| NDC Item | 69238137403 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1374-3) / 5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1374 |
NDC Item 69238137506
| NDC 9 | 69238-1375 |
|---|---|
| NDC 10 | 69238-1375-6 |
| NDC Item | 69238137506 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1375-6) / 10 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1375 |
NDC Item 70518399400
| NDC 9 | 70518-3994 |
|---|---|
| NDC 10 | 70518-3994-0 |
| NDC Item | 70518399400 |
| Packaging | 5 mL in 1 BOTTLE (70518-3994-0) |
| FDA SPL set id | 766955 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2024-01-24 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 70518-3994 |
NDC Item 72162112802
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-2 |
| NDC Item | 72162112802 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (72162-1128-2) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112804
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-4 |
| NDC Item | 72162112804 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (72162-1128-4) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112807
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-7 |
| NDC Item | 72162112807 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (72162-1128-7) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 80425026001
| NDC 9 | 80425-0260 |
|---|---|
| NDC 10 | 80425-0260-1 |
| NDC Item | 80425026001 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (80425-0260-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 848958 |
| Labeler | Advanced Rx Pharmacy of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 80425-0260 |
NDC Item 80425036601
| NDC 9 | 80425-0366 |
|---|---|
| NDC 10 | 80425-0366-1 |
| NDC Item | 80425036601 |
| Packaging | 5 mL in 1 BOTTLE (80425-0366-1) |
| FDA SPL set id | 847557 |
| Labeler | Advanced Rx of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2023-11-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 80425-0366 |
NDC Item 00574403105
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-05 |
| NDC Item | 00574403105 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (0574-4031-05) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403110
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-10 |
| NDC Item | 00574403110 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (0574-4031-10) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403125
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-25 |
| NDC Item | 00574403125 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (0574-4031-25) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 24208029505
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-05 |
| NDC Item | 24208029505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029510
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-10 |
| NDC Item | 24208029510 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-10) / 10 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029525
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-25 |
| NDC Item | 24208029525 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-25) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 50090113500
| NDC 9 | 50090-1135 |
|---|---|
| NDC 10 | 50090-1135-0 |
| NDC Item | 50090113500 |
| Packaging | 2.5 mL in 1 BOTTLE (50090-1135-0) |
| FDA SPL set id | 718677 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1135 |
NDC Item 50090113600
| NDC 9 | 50090-1136 |
|---|---|
| NDC 10 | 50090-1136-0 |
| NDC Item | 50090113600 |
| Packaging | 5 mL in 1 BOTTLE (50090-1136-0) |
| FDA SPL set id | 803024 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1136 |
NDC Item 50090189300
| NDC 9 | 50090-1893 |
|---|---|
| NDC 10 | 50090-1893-0 |
| NDC Item | 50090189300 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1893-0) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 771442 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1893 |
NDC Item 50090191400
| NDC 9 | 50090-1914 |
|---|---|
| NDC 10 | 50090-1914-0 |
| NDC Item | 50090191400 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1914-0) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 693387 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1914 |
NDC Item 50090726700
| NDC 9 | 50090-7267 |
|---|---|
| NDC 10 | 50090-7267-0 |
| NDC Item | 50090726700 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (50090-7267-0) |
| ANDA | ANDA212715 |
| FDA SPL set id | 817223 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-7267 |
NDC Item 52959098401
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-01 |
| NDC Item | 52959098401 |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 52959098410
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-10 |
| NDC Item | 52959098410 |
| Packaging | 10 mL in 1 BOTTLE (52959-984-10) |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 55700091505
| NDC 9 | 55700-915 |
|---|---|
| NDC 10 | 55700-915-05 |
| NDC Item | 55700091505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (55700-915-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 653524 |
| Labeler | Quality Care Products, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55700-915 |
NDC Item 61314064705
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-05 |
| NDC Item | 61314064705 |
| Packaging | 5 mL in 1 BOTTLE (61314-647-05) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064710
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-10 |
| NDC Item | 61314064710 |
| Packaging | 10 mL in 1 BOTTLE (61314-647-10) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064725
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-25 |
| NDC Item | 61314064725 |
| Packaging | 2.5 mL in 1 BOTTLE (61314-647-25) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 63629957001
| NDC 9 | 63629-9570 |
|---|---|
| NDC 10 | 63629-9570-1 |
| NDC Item | 63629957001 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (63629-9570-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763323 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9570 |
NDC Item 63629957101
| NDC 9 | 63629-9571 |
|---|---|
| NDC 10 | 63629-9571-1 |
| NDC Item | 63629957101 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (63629-9571-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763569 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9571 |
NDC Item 63629957201
| NDC 9 | 63629-9572 |
|---|---|
| NDC 10 | 63629-9572-1 |
| NDC Item | 63629957201 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (63629-9572-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763269 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9572 |
NDC Item 67296066501
| NDC 9 | 67296-0665 |
|---|---|
| NDC 10 | 67296-0665-1 |
| NDC Item | 67296066501 |
| Packaging | 5 mL in 1 BOTTLE (67296-0665-1) |
| FDA SPL set id | 813479 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 67296-0665 |
NDC Item 68071182102
| NDC 9 | 68071-1821 |
|---|---|
| NDC 10 | 68071-1821-2 |
| NDC Item | 68071182102 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (68071-1821-2) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 858986 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-1821 |
NDC Item 68071420305
| NDC 9 | 68071-4203 |
|---|---|
| NDC 10 | 68071-4203-5 |
| NDC Item | 68071420305 |
| Packaging | 5 mL in 1 BOX (68071-4203-5) |
| ANDA | ANDA064134 |
| FDA SPL set id | 790175 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-4203 |
NDC Item 69238137302
| NDC 9 | 69238-1373 |
|---|---|
| NDC 10 | 69238-1373-2 |
| NDC Item | 69238137302 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1373-2) / 2.5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1373 |
NDC Item 69238137403
| NDC 9 | 69238-1374 |
|---|---|
| NDC 10 | 69238-1374-3 |
| NDC Item | 69238137403 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1374-3) / 5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1374 |
NDC Item 69238137506
| NDC 9 | 69238-1375 |
|---|---|
| NDC 10 | 69238-1375-6 |
| NDC Item | 69238137506 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1375-6) / 10 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1375 |
NDC Item 70518399400
| NDC 9 | 70518-3994 |
|---|---|
| NDC 10 | 70518-3994-0 |
| NDC Item | 70518399400 |
| Packaging | 5 mL in 1 BOTTLE (70518-3994-0) |
| FDA SPL set id | 766955 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2024-01-24 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 70518-3994 |
NDC Item 72162112802
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-2 |
| NDC Item | 72162112802 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (72162-1128-2) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112804
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-4 |
| NDC Item | 72162112804 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (72162-1128-4) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112807
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-7 |
| NDC Item | 72162112807 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (72162-1128-7) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 80425026001
| NDC 9 | 80425-0260 |
|---|---|
| NDC 10 | 80425-0260-1 |
| NDC Item | 80425026001 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (80425-0260-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 848958 |
| Labeler | Advanced Rx Pharmacy of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 80425-0260 |
NDC Item 80425036601
| NDC 9 | 80425-0366 |
|---|---|
| NDC 10 | 80425-0366-1 |
| NDC Item | 80425036601 |
| Packaging | 5 mL in 1 BOTTLE (80425-0366-1) |
| FDA SPL set id | 847557 |
| Labeler | Advanced Rx of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2023-11-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 80425-0366 |
NDC Item 00574403105
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-05 |
| NDC Item | 00574403105 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (0574-4031-05) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403110
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-10 |
| NDC Item | 00574403110 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (0574-4031-10) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403125
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-25 |
| NDC Item | 00574403125 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (0574-4031-25) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 24208029505
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-05 |
| NDC Item | 24208029505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029510
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-10 |
| NDC Item | 24208029510 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-10) / 10 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029525
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-25 |
| NDC Item | 24208029525 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-25) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 50090113500
| NDC 9 | 50090-1135 |
|---|---|
| NDC 10 | 50090-1135-0 |
| NDC Item | 50090113500 |
| Packaging | 2.5 mL in 1 BOTTLE (50090-1135-0) |
| FDA SPL set id | 718677 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1135 |
NDC Item 50090113600
| NDC 9 | 50090-1136 |
|---|---|
| NDC 10 | 50090-1136-0 |
| NDC Item | 50090113600 |
| Packaging | 5 mL in 1 BOTTLE (50090-1136-0) |
| FDA SPL set id | 803024 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1136 |
NDC Item 50090189300
| NDC 9 | 50090-1893 |
|---|---|
| NDC 10 | 50090-1893-0 |
| NDC Item | 50090189300 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1893-0) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 771442 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1893 |
NDC Item 50090191400
| NDC 9 | 50090-1914 |
|---|---|
| NDC 10 | 50090-1914-0 |
| NDC Item | 50090191400 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1914-0) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 693387 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1914 |
NDC Item 50090726700
| NDC 9 | 50090-7267 |
|---|---|
| NDC 10 | 50090-7267-0 |
| NDC Item | 50090726700 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (50090-7267-0) |
| ANDA | ANDA212715 |
| FDA SPL set id | 817223 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-7267 |
NDC Item 52959098401
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-01 |
| NDC Item | 52959098401 |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 52959098410
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-10 |
| NDC Item | 52959098410 |
| Packaging | 10 mL in 1 BOTTLE (52959-984-10) |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 55700091505
| NDC 9 | 55700-915 |
|---|---|
| NDC 10 | 55700-915-05 |
| NDC Item | 55700091505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (55700-915-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 653524 |
| Labeler | Quality Care Products, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55700-915 |
NDC Item 61314064705
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-05 |
| NDC Item | 61314064705 |
| Packaging | 5 mL in 1 BOTTLE (61314-647-05) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064710
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-10 |
| NDC Item | 61314064710 |
| Packaging | 10 mL in 1 BOTTLE (61314-647-10) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064725
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-25 |
| NDC Item | 61314064725 |
| Packaging | 2.5 mL in 1 BOTTLE (61314-647-25) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 63629957001
| NDC 9 | 63629-9570 |
|---|---|
| NDC 10 | 63629-9570-1 |
| NDC Item | 63629957001 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (63629-9570-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763323 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9570 |
NDC Item 63629957101
| NDC 9 | 63629-9571 |
|---|---|
| NDC 10 | 63629-9571-1 |
| NDC Item | 63629957101 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (63629-9571-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763569 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9571 |
NDC Item 63629957201
| NDC 9 | 63629-9572 |
|---|---|
| NDC 10 | 63629-9572-1 |
| NDC Item | 63629957201 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (63629-9572-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763269 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9572 |
NDC Item 67296066501
| NDC 9 | 67296-0665 |
|---|---|
| NDC 10 | 67296-0665-1 |
| NDC Item | 67296066501 |
| Packaging | 5 mL in 1 BOTTLE (67296-0665-1) |
| FDA SPL set id | 813479 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 67296-0665 |
NDC Item 68071182102
| NDC 9 | 68071-1821 |
|---|---|
| NDC 10 | 68071-1821-2 |
| NDC Item | 68071182102 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (68071-1821-2) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 858986 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-1821 |
NDC Item 68071420305
| NDC 9 | 68071-4203 |
|---|---|
| NDC 10 | 68071-4203-5 |
| NDC Item | 68071420305 |
| Packaging | 5 mL in 1 BOX (68071-4203-5) |
| ANDA | ANDA064134 |
| FDA SPL set id | 790175 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-4203 |
NDC Item 69238137302
| NDC 9 | 69238-1373 |
|---|---|
| NDC 10 | 69238-1373-2 |
| NDC Item | 69238137302 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1373-2) / 2.5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1373 |
NDC Item 69238137403
| NDC 9 | 69238-1374 |
|---|---|
| NDC 10 | 69238-1374-3 |
| NDC Item | 69238137403 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1374-3) / 5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1374 |
NDC Item 69238137506
| NDC 9 | 69238-1375 |
|---|---|
| NDC 10 | 69238-1375-6 |
| NDC Item | 69238137506 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1375-6) / 10 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1375 |
NDC Item 70518399400
| NDC 9 | 70518-3994 |
|---|---|
| NDC 10 | 70518-3994-0 |
| NDC Item | 70518399400 |
| Packaging | 5 mL in 1 BOTTLE (70518-3994-0) |
| FDA SPL set id | 766955 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2024-01-24 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 70518-3994 |
NDC Item 72162112802
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-2 |
| NDC Item | 72162112802 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (72162-1128-2) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112804
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-4 |
| NDC Item | 72162112804 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (72162-1128-4) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112807
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-7 |
| NDC Item | 72162112807 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (72162-1128-7) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 80425026001
| NDC 9 | 80425-0260 |
|---|---|
| NDC 10 | 80425-0260-1 |
| NDC Item | 80425026001 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (80425-0260-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 848958 |
| Labeler | Advanced Rx Pharmacy of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 80425-0260 |
NDC Item 80425036601
| NDC 9 | 80425-0366 |
|---|---|
| NDC 10 | 80425-0366-1 |
| NDC Item | 80425036601 |
| Packaging | 5 mL in 1 BOTTLE (80425-0366-1) |
| FDA SPL set id | 847557 |
| Labeler | Advanced Rx of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2023-11-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 80425-0366 |
NDC Item 00574403105
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-05 |
| NDC Item | 00574403105 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (0574-4031-05) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403110
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-10 |
| NDC Item | 00574403110 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (0574-4031-10) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403125
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-25 |
| NDC Item | 00574403125 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (0574-4031-25) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 24208029505
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-05 |
| NDC Item | 24208029505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029510
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-10 |
| NDC Item | 24208029510 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-10) / 10 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029525
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-25 |
| NDC Item | 24208029525 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-25) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 50090113500
| NDC 9 | 50090-1135 |
|---|---|
| NDC 10 | 50090-1135-0 |
| NDC Item | 50090113500 |
| Packaging | 2.5 mL in 1 BOTTLE (50090-1135-0) |
| FDA SPL set id | 718677 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1135 |
NDC Item 50090113600
| NDC 9 | 50090-1136 |
|---|---|
| NDC 10 | 50090-1136-0 |
| NDC Item | 50090113600 |
| Packaging | 5 mL in 1 BOTTLE (50090-1136-0) |
| FDA SPL set id | 803024 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1136 |
NDC Item 50090189300
| NDC 9 | 50090-1893 |
|---|---|
| NDC 10 | 50090-1893-0 |
| NDC Item | 50090189300 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1893-0) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 771442 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1893 |
NDC Item 50090191400
| NDC 9 | 50090-1914 |
|---|---|
| NDC 10 | 50090-1914-0 |
| NDC Item | 50090191400 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1914-0) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 693387 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1914 |
NDC Item 50090726700
| NDC 9 | 50090-7267 |
|---|---|
| NDC 10 | 50090-7267-0 |
| NDC Item | 50090726700 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (50090-7267-0) |
| ANDA | ANDA212715 |
| FDA SPL set id | 817223 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-7267 |
NDC Item 52959098401
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-01 |
| NDC Item | 52959098401 |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 52959098410
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-10 |
| NDC Item | 52959098410 |
| Packaging | 10 mL in 1 BOTTLE (52959-984-10) |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 55700091505
| NDC 9 | 55700-915 |
|---|---|
| NDC 10 | 55700-915-05 |
| NDC Item | 55700091505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (55700-915-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 653524 |
| Labeler | Quality Care Products, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55700-915 |
NDC Item 61314064705
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-05 |
| NDC Item | 61314064705 |
| Packaging | 5 mL in 1 BOTTLE (61314-647-05) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064710
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-10 |
| NDC Item | 61314064710 |
| Packaging | 10 mL in 1 BOTTLE (61314-647-10) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064725
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-25 |
| NDC Item | 61314064725 |
| Packaging | 2.5 mL in 1 BOTTLE (61314-647-25) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 63629957001
| NDC 9 | 63629-9570 |
|---|---|
| NDC 10 | 63629-9570-1 |
| NDC Item | 63629957001 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (63629-9570-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763323 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9570 |
NDC Item 63629957101
| NDC 9 | 63629-9571 |
|---|---|
| NDC 10 | 63629-9571-1 |
| NDC Item | 63629957101 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (63629-9571-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763569 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9571 |
NDC Item 63629957201
| NDC 9 | 63629-9572 |
|---|---|
| NDC 10 | 63629-9572-1 |
| NDC Item | 63629957201 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (63629-9572-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763269 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9572 |
NDC Item 67296066501
| NDC 9 | 67296-0665 |
|---|---|
| NDC 10 | 67296-0665-1 |
| NDC Item | 67296066501 |
| Packaging | 5 mL in 1 BOTTLE (67296-0665-1) |
| FDA SPL set id | 813479 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 67296-0665 |
NDC Item 68071182102
| NDC 9 | 68071-1821 |
|---|---|
| NDC 10 | 68071-1821-2 |
| NDC Item | 68071182102 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (68071-1821-2) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 858986 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-1821 |
NDC Item 68071420305
| NDC 9 | 68071-4203 |
|---|---|
| NDC 10 | 68071-4203-5 |
| NDC Item | 68071420305 |
| Packaging | 5 mL in 1 BOX (68071-4203-5) |
| ANDA | ANDA064134 |
| FDA SPL set id | 790175 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-4203 |
NDC Item 69238137302
| NDC 9 | 69238-1373 |
|---|---|
| NDC 10 | 69238-1373-2 |
| NDC Item | 69238137302 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1373-2) / 2.5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1373 |
NDC Item 69238137403
| NDC 9 | 69238-1374 |
|---|---|
| NDC 10 | 69238-1374-3 |
| NDC Item | 69238137403 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1374-3) / 5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1374 |
NDC Item 69238137506
| NDC 9 | 69238-1375 |
|---|---|
| NDC 10 | 69238-1375-6 |
| NDC Item | 69238137506 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1375-6) / 10 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1375 |
NDC Item 70518399400
| NDC 9 | 70518-3994 |
|---|---|
| NDC 10 | 70518-3994-0 |
| NDC Item | 70518399400 |
| Packaging | 5 mL in 1 BOTTLE (70518-3994-0) |
| FDA SPL set id | 766955 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2024-01-24 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 70518-3994 |
NDC Item 72162112802
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-2 |
| NDC Item | 72162112802 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (72162-1128-2) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112804
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-4 |
| NDC Item | 72162112804 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (72162-1128-4) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112807
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-7 |
| NDC Item | 72162112807 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (72162-1128-7) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 80425026001
| NDC 9 | 80425-0260 |
|---|---|
| NDC 10 | 80425-0260-1 |
| NDC Item | 80425026001 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (80425-0260-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 848958 |
| Labeler | Advanced Rx Pharmacy of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 80425-0260 |
NDC Item 80425036601
| NDC 9 | 80425-0366 |
|---|---|
| NDC 10 | 80425-0366-1 |
| NDC Item | 80425036601 |
| Packaging | 5 mL in 1 BOTTLE (80425-0366-1) |
| FDA SPL set id | 847557 |
| Labeler | Advanced Rx of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2023-11-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 80425-0366 |
NDC Item 00574403105
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-05 |
| NDC Item | 00574403105 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (0574-4031-05) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403110
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-10 |
| NDC Item | 00574403110 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (0574-4031-10) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403125
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-25 |
| NDC Item | 00574403125 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (0574-4031-25) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 24208029505
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-05 |
| NDC Item | 24208029505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029510
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-10 |
| NDC Item | 24208029510 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-10) / 10 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029525
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-25 |
| NDC Item | 24208029525 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-25) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 50090113500
| NDC 9 | 50090-1135 |
|---|---|
| NDC 10 | 50090-1135-0 |
| NDC Item | 50090113500 |
| Packaging | 2.5 mL in 1 BOTTLE (50090-1135-0) |
| FDA SPL set id | 718677 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1135 |
NDC Item 50090113600
| NDC 9 | 50090-1136 |
|---|---|
| NDC 10 | 50090-1136-0 |
| NDC Item | 50090113600 |
| Packaging | 5 mL in 1 BOTTLE (50090-1136-0) |
| FDA SPL set id | 803024 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1136 |
NDC Item 50090189300
| NDC 9 | 50090-1893 |
|---|---|
| NDC 10 | 50090-1893-0 |
| NDC Item | 50090189300 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1893-0) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 771442 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1893 |
NDC Item 50090191400
| NDC 9 | 50090-1914 |
|---|---|
| NDC 10 | 50090-1914-0 |
| NDC Item | 50090191400 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1914-0) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 693387 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1914 |
NDC Item 50090726700
| NDC 9 | 50090-7267 |
|---|---|
| NDC 10 | 50090-7267-0 |
| NDC Item | 50090726700 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (50090-7267-0) |
| ANDA | ANDA212715 |
| FDA SPL set id | 817223 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-7267 |
NDC Item 52959098401
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-01 |
| NDC Item | 52959098401 |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 52959098410
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-10 |
| NDC Item | 52959098410 |
| Packaging | 10 mL in 1 BOTTLE (52959-984-10) |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 55700091505
| NDC 9 | 55700-915 |
|---|---|
| NDC 10 | 55700-915-05 |
| NDC Item | 55700091505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (55700-915-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 653524 |
| Labeler | Quality Care Products, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55700-915 |
NDC Item 61314064705
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-05 |
| NDC Item | 61314064705 |
| Packaging | 5 mL in 1 BOTTLE (61314-647-05) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064710
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-10 |
| NDC Item | 61314064710 |
| Packaging | 10 mL in 1 BOTTLE (61314-647-10) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064725
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-25 |
| NDC Item | 61314064725 |
| Packaging | 2.5 mL in 1 BOTTLE (61314-647-25) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 63629957001
| NDC 9 | 63629-9570 |
|---|---|
| NDC 10 | 63629-9570-1 |
| NDC Item | 63629957001 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (63629-9570-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763323 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9570 |
NDC Item 63629957101
| NDC 9 | 63629-9571 |
|---|---|
| NDC 10 | 63629-9571-1 |
| NDC Item | 63629957101 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (63629-9571-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763569 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9571 |
NDC Item 63629957201
| NDC 9 | 63629-9572 |
|---|---|
| NDC 10 | 63629-9572-1 |
| NDC Item | 63629957201 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (63629-9572-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763269 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9572 |
NDC Item 67296066501
| NDC 9 | 67296-0665 |
|---|---|
| NDC 10 | 67296-0665-1 |
| NDC Item | 67296066501 |
| Packaging | 5 mL in 1 BOTTLE (67296-0665-1) |
| FDA SPL set id | 813479 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 67296-0665 |
NDC Item 68071182102
| NDC 9 | 68071-1821 |
|---|---|
| NDC 10 | 68071-1821-2 |
| NDC Item | 68071182102 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (68071-1821-2) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 858986 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-1821 |
NDC Item 68071420305
| NDC 9 | 68071-4203 |
|---|---|
| NDC 10 | 68071-4203-5 |
| NDC Item | 68071420305 |
| Packaging | 5 mL in 1 BOX (68071-4203-5) |
| ANDA | ANDA064134 |
| FDA SPL set id | 790175 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-4203 |
NDC Item 69238137302
| NDC 9 | 69238-1373 |
|---|---|
| NDC 10 | 69238-1373-2 |
| NDC Item | 69238137302 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1373-2) / 2.5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1373 |
NDC Item 69238137403
| NDC 9 | 69238-1374 |
|---|---|
| NDC 10 | 69238-1374-3 |
| NDC Item | 69238137403 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1374-3) / 5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1374 |
NDC Item 69238137506
| NDC 9 | 69238-1375 |
|---|---|
| NDC 10 | 69238-1375-6 |
| NDC Item | 69238137506 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1375-6) / 10 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1375 |
NDC Item 70518399400
| NDC 9 | 70518-3994 |
|---|---|
| NDC 10 | 70518-3994-0 |
| NDC Item | 70518399400 |
| Packaging | 5 mL in 1 BOTTLE (70518-3994-0) |
| FDA SPL set id | 766955 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2024-01-24 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 70518-3994 |
NDC Item 72162112802
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-2 |
| NDC Item | 72162112802 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (72162-1128-2) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112804
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-4 |
| NDC Item | 72162112804 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (72162-1128-4) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112807
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-7 |
| NDC Item | 72162112807 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (72162-1128-7) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 80425026001
| NDC 9 | 80425-0260 |
|---|---|
| NDC 10 | 80425-0260-1 |
| NDC Item | 80425026001 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (80425-0260-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 848958 |
| Labeler | Advanced Rx Pharmacy of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 80425-0260 |
NDC Item 80425036601
| NDC 9 | 80425-0366 |
|---|---|
| NDC 10 | 80425-0366-1 |
| NDC Item | 80425036601 |
| Packaging | 5 mL in 1 BOTTLE (80425-0366-1) |
| FDA SPL set id | 847557 |
| Labeler | Advanced Rx of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2023-11-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 80425-0366 |
NDC Item 00574403105
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-05 |
| NDC Item | 00574403105 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (0574-4031-05) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403110
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-10 |
| NDC Item | 00574403110 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (0574-4031-10) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403125
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-25 |
| NDC Item | 00574403125 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (0574-4031-25) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 24208029505
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-05 |
| NDC Item | 24208029505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029510
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-10 |
| NDC Item | 24208029510 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-10) / 10 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029525
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-25 |
| NDC Item | 24208029525 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-25) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 50090113500
| NDC 9 | 50090-1135 |
|---|---|
| NDC 10 | 50090-1135-0 |
| NDC Item | 50090113500 |
| Packaging | 2.5 mL in 1 BOTTLE (50090-1135-0) |
| FDA SPL set id | 718677 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1135 |
NDC Item 50090113600
| NDC 9 | 50090-1136 |
|---|---|
| NDC 10 | 50090-1136-0 |
| NDC Item | 50090113600 |
| Packaging | 5 mL in 1 BOTTLE (50090-1136-0) |
| FDA SPL set id | 803024 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1136 |
NDC Item 50090189300
| NDC 9 | 50090-1893 |
|---|---|
| NDC 10 | 50090-1893-0 |
| NDC Item | 50090189300 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1893-0) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 771442 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1893 |
NDC Item 50090191400
| NDC 9 | 50090-1914 |
|---|---|
| NDC 10 | 50090-1914-0 |
| NDC Item | 50090191400 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1914-0) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 693387 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1914 |
NDC Item 50090726700
| NDC 9 | 50090-7267 |
|---|---|
| NDC 10 | 50090-7267-0 |
| NDC Item | 50090726700 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (50090-7267-0) |
| ANDA | ANDA212715 |
| FDA SPL set id | 817223 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-7267 |
NDC Item 52959098401
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-01 |
| NDC Item | 52959098401 |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 52959098410
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-10 |
| NDC Item | 52959098410 |
| Packaging | 10 mL in 1 BOTTLE (52959-984-10) |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 55700091505
| NDC 9 | 55700-915 |
|---|---|
| NDC 10 | 55700-915-05 |
| NDC Item | 55700091505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (55700-915-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 653524 |
| Labeler | Quality Care Products, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55700-915 |
NDC Item 61314064705
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-05 |
| NDC Item | 61314064705 |
| Packaging | 5 mL in 1 BOTTLE (61314-647-05) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064710
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-10 |
| NDC Item | 61314064710 |
| Packaging | 10 mL in 1 BOTTLE (61314-647-10) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064725
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-25 |
| NDC Item | 61314064725 |
| Packaging | 2.5 mL in 1 BOTTLE (61314-647-25) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 63629957001
| NDC 9 | 63629-9570 |
|---|---|
| NDC 10 | 63629-9570-1 |
| NDC Item | 63629957001 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (63629-9570-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763323 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9570 |
NDC Item 63629957101
| NDC 9 | 63629-9571 |
|---|---|
| NDC 10 | 63629-9571-1 |
| NDC Item | 63629957101 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (63629-9571-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763569 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9571 |
NDC Item 63629957201
| NDC 9 | 63629-9572 |
|---|---|
| NDC 10 | 63629-9572-1 |
| NDC Item | 63629957201 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (63629-9572-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763269 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9572 |
NDC Item 67296066501
| NDC 9 | 67296-0665 |
|---|---|
| NDC 10 | 67296-0665-1 |
| NDC Item | 67296066501 |
| Packaging | 5 mL in 1 BOTTLE (67296-0665-1) |
| FDA SPL set id | 813479 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 67296-0665 |
NDC Item 68071182102
| NDC 9 | 68071-1821 |
|---|---|
| NDC 10 | 68071-1821-2 |
| NDC Item | 68071182102 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (68071-1821-2) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 858986 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-1821 |
NDC Item 68071420305
| NDC 9 | 68071-4203 |
|---|---|
| NDC 10 | 68071-4203-5 |
| NDC Item | 68071420305 |
| Packaging | 5 mL in 1 BOX (68071-4203-5) |
| ANDA | ANDA064134 |
| FDA SPL set id | 790175 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-4203 |
NDC Item 69238137302
| NDC 9 | 69238-1373 |
|---|---|
| NDC 10 | 69238-1373-2 |
| NDC Item | 69238137302 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1373-2) / 2.5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1373 |
NDC Item 69238137403
| NDC 9 | 69238-1374 |
|---|---|
| NDC 10 | 69238-1374-3 |
| NDC Item | 69238137403 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1374-3) / 5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1374 |
NDC Item 69238137506
| NDC 9 | 69238-1375 |
|---|---|
| NDC 10 | 69238-1375-6 |
| NDC Item | 69238137506 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1375-6) / 10 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1375 |
NDC Item 70518399400
| NDC 9 | 70518-3994 |
|---|---|
| NDC 10 | 70518-3994-0 |
| NDC Item | 70518399400 |
| Packaging | 5 mL in 1 BOTTLE (70518-3994-0) |
| FDA SPL set id | 766955 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2024-01-24 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 70518-3994 |
NDC Item 72162112802
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-2 |
| NDC Item | 72162112802 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (72162-1128-2) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112804
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-4 |
| NDC Item | 72162112804 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (72162-1128-4) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112807
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-7 |
| NDC Item | 72162112807 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (72162-1128-7) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 80425026001
| NDC 9 | 80425-0260 |
|---|---|
| NDC 10 | 80425-0260-1 |
| NDC Item | 80425026001 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (80425-0260-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 848958 |
| Labeler | Advanced Rx Pharmacy of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 80425-0260 |
NDC Item 80425036601
| NDC 9 | 80425-0366 |
|---|---|
| NDC 10 | 80425-0366-1 |
| NDC Item | 80425036601 |
| Packaging | 5 mL in 1 BOTTLE (80425-0366-1) |
| FDA SPL set id | 847557 |
| Labeler | Advanced Rx of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2023-11-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 80425-0366 |
NDC Item 00574403105
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-05 |
| NDC Item | 00574403105 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (0574-4031-05) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403110
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-10 |
| NDC Item | 00574403110 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (0574-4031-10) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403125
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-25 |
| NDC Item | 00574403125 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (0574-4031-25) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 24208029505
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-05 |
| NDC Item | 24208029505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029510
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-10 |
| NDC Item | 24208029510 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-10) / 10 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029525
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-25 |
| NDC Item | 24208029525 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-25) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 50090113500
| NDC 9 | 50090-1135 |
|---|---|
| NDC 10 | 50090-1135-0 |
| NDC Item | 50090113500 |
| Packaging | 2.5 mL in 1 BOTTLE (50090-1135-0) |
| FDA SPL set id | 718677 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1135 |
NDC Item 50090113600
| NDC 9 | 50090-1136 |
|---|---|
| NDC 10 | 50090-1136-0 |
| NDC Item | 50090113600 |
| Packaging | 5 mL in 1 BOTTLE (50090-1136-0) |
| FDA SPL set id | 803024 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1136 |
NDC Item 50090189300
| NDC 9 | 50090-1893 |
|---|---|
| NDC 10 | 50090-1893-0 |
| NDC Item | 50090189300 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1893-0) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 771442 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1893 |
NDC Item 50090191400
| NDC 9 | 50090-1914 |
|---|---|
| NDC 10 | 50090-1914-0 |
| NDC Item | 50090191400 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1914-0) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 693387 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1914 |
NDC Item 50090726700
| NDC 9 | 50090-7267 |
|---|---|
| NDC 10 | 50090-7267-0 |
| NDC Item | 50090726700 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (50090-7267-0) |
| ANDA | ANDA212715 |
| FDA SPL set id | 817223 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-7267 |
NDC Item 52959098401
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-01 |
| NDC Item | 52959098401 |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 52959098410
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-10 |
| NDC Item | 52959098410 |
| Packaging | 10 mL in 1 BOTTLE (52959-984-10) |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 55700091505
| NDC 9 | 55700-915 |
|---|---|
| NDC 10 | 55700-915-05 |
| NDC Item | 55700091505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (55700-915-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 653524 |
| Labeler | Quality Care Products, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55700-915 |
NDC Item 61314064705
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-05 |
| NDC Item | 61314064705 |
| Packaging | 5 mL in 1 BOTTLE (61314-647-05) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064710
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-10 |
| NDC Item | 61314064710 |
| Packaging | 10 mL in 1 BOTTLE (61314-647-10) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064725
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-25 |
| NDC Item | 61314064725 |
| Packaging | 2.5 mL in 1 BOTTLE (61314-647-25) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 63629957001
| NDC 9 | 63629-9570 |
|---|---|
| NDC 10 | 63629-9570-1 |
| NDC Item | 63629957001 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (63629-9570-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763323 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9570 |
NDC Item 63629957101
| NDC 9 | 63629-9571 |
|---|---|
| NDC 10 | 63629-9571-1 |
| NDC Item | 63629957101 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (63629-9571-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763569 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9571 |
NDC Item 63629957201
| NDC 9 | 63629-9572 |
|---|---|
| NDC 10 | 63629-9572-1 |
| NDC Item | 63629957201 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (63629-9572-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763269 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9572 |
NDC Item 67296066501
| NDC 9 | 67296-0665 |
|---|---|
| NDC 10 | 67296-0665-1 |
| NDC Item | 67296066501 |
| Packaging | 5 mL in 1 BOTTLE (67296-0665-1) |
| FDA SPL set id | 813479 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 67296-0665 |
NDC Item 68071182102
| NDC 9 | 68071-1821 |
|---|---|
| NDC 10 | 68071-1821-2 |
| NDC Item | 68071182102 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (68071-1821-2) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 858986 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-1821 |
NDC Item 68071420305
| NDC 9 | 68071-4203 |
|---|---|
| NDC 10 | 68071-4203-5 |
| NDC Item | 68071420305 |
| Packaging | 5 mL in 1 BOX (68071-4203-5) |
| ANDA | ANDA064134 |
| FDA SPL set id | 790175 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-4203 |
NDC Item 69238137302
| NDC 9 | 69238-1373 |
|---|---|
| NDC 10 | 69238-1373-2 |
| NDC Item | 69238137302 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1373-2) / 2.5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1373 |
NDC Item 69238137403
| NDC 9 | 69238-1374 |
|---|---|
| NDC 10 | 69238-1374-3 |
| NDC Item | 69238137403 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1374-3) / 5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1374 |
NDC Item 69238137506
| NDC 9 | 69238-1375 |
|---|---|
| NDC 10 | 69238-1375-6 |
| NDC Item | 69238137506 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1375-6) / 10 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1375 |
NDC Item 70518399400
| NDC 9 | 70518-3994 |
|---|---|
| NDC 10 | 70518-3994-0 |
| NDC Item | 70518399400 |
| Packaging | 5 mL in 1 BOTTLE (70518-3994-0) |
| FDA SPL set id | 766955 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2024-01-24 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 70518-3994 |
NDC Item 72162112802
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-2 |
| NDC Item | 72162112802 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (72162-1128-2) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112804
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-4 |
| NDC Item | 72162112804 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (72162-1128-4) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112807
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-7 |
| NDC Item | 72162112807 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (72162-1128-7) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 80425026001
| NDC 9 | 80425-0260 |
|---|---|
| NDC 10 | 80425-0260-1 |
| NDC Item | 80425026001 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (80425-0260-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 848958 |
| Labeler | Advanced Rx Pharmacy of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 80425-0260 |
NDC Item 80425036601
| NDC 9 | 80425-0366 |
|---|---|
| NDC 10 | 80425-0366-1 |
| NDC Item | 80425036601 |
| Packaging | 5 mL in 1 BOTTLE (80425-0366-1) |
| FDA SPL set id | 847557 |
| Labeler | Advanced Rx of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2023-11-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 80425-0366 |
NDC Item 00574403105
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-05 |
| NDC Item | 00574403105 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (0574-4031-05) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403110
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-10 |
| NDC Item | 00574403110 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (0574-4031-10) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403125
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-25 |
| NDC Item | 00574403125 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (0574-4031-25) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 24208029505
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-05 |
| NDC Item | 24208029505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029510
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-10 |
| NDC Item | 24208029510 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-10) / 10 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029525
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-25 |
| NDC Item | 24208029525 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-25) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 50090113500
| NDC 9 | 50090-1135 |
|---|---|
| NDC 10 | 50090-1135-0 |
| NDC Item | 50090113500 |
| Packaging | 2.5 mL in 1 BOTTLE (50090-1135-0) |
| FDA SPL set id | 718677 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1135 |
NDC Item 50090113600
| NDC 9 | 50090-1136 |
|---|---|
| NDC 10 | 50090-1136-0 |
| NDC Item | 50090113600 |
| Packaging | 5 mL in 1 BOTTLE (50090-1136-0) |
| FDA SPL set id | 803024 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1136 |
NDC Item 50090189300
| NDC 9 | 50090-1893 |
|---|---|
| NDC 10 | 50090-1893-0 |
| NDC Item | 50090189300 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1893-0) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 771442 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1893 |
NDC Item 50090191400
| NDC 9 | 50090-1914 |
|---|---|
| NDC 10 | 50090-1914-0 |
| NDC Item | 50090191400 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1914-0) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 693387 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1914 |
NDC Item 50090726700
| NDC 9 | 50090-7267 |
|---|---|
| NDC 10 | 50090-7267-0 |
| NDC Item | 50090726700 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (50090-7267-0) |
| ANDA | ANDA212715 |
| FDA SPL set id | 817223 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-7267 |
NDC Item 52959098401
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-01 |
| NDC Item | 52959098401 |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 52959098410
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-10 |
| NDC Item | 52959098410 |
| Packaging | 10 mL in 1 BOTTLE (52959-984-10) |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 55700091505
| NDC 9 | 55700-915 |
|---|---|
| NDC 10 | 55700-915-05 |
| NDC Item | 55700091505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (55700-915-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 653524 |
| Labeler | Quality Care Products, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55700-915 |
NDC Item 61314064705
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-05 |
| NDC Item | 61314064705 |
| Packaging | 5 mL in 1 BOTTLE (61314-647-05) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064710
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-10 |
| NDC Item | 61314064710 |
| Packaging | 10 mL in 1 BOTTLE (61314-647-10) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064725
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-25 |
| NDC Item | 61314064725 |
| Packaging | 2.5 mL in 1 BOTTLE (61314-647-25) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 63629957001
| NDC 9 | 63629-9570 |
|---|---|
| NDC 10 | 63629-9570-1 |
| NDC Item | 63629957001 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (63629-9570-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763323 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9570 |
NDC Item 63629957101
| NDC 9 | 63629-9571 |
|---|---|
| NDC 10 | 63629-9571-1 |
| NDC Item | 63629957101 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (63629-9571-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763569 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9571 |
NDC Item 63629957201
| NDC 9 | 63629-9572 |
|---|---|
| NDC 10 | 63629-9572-1 |
| NDC Item | 63629957201 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (63629-9572-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763269 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9572 |
NDC Item 67296066501
| NDC 9 | 67296-0665 |
|---|---|
| NDC 10 | 67296-0665-1 |
| NDC Item | 67296066501 |
| Packaging | 5 mL in 1 BOTTLE (67296-0665-1) |
| FDA SPL set id | 813479 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 67296-0665 |
NDC Item 68071182102
| NDC 9 | 68071-1821 |
|---|---|
| NDC 10 | 68071-1821-2 |
| NDC Item | 68071182102 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (68071-1821-2) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 858986 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-1821 |
NDC Item 68071420305
| NDC 9 | 68071-4203 |
|---|---|
| NDC 10 | 68071-4203-5 |
| NDC Item | 68071420305 |
| Packaging | 5 mL in 1 BOX (68071-4203-5) |
| ANDA | ANDA064134 |
| FDA SPL set id | 790175 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-4203 |
NDC Item 69238137302
| NDC 9 | 69238-1373 |
|---|---|
| NDC 10 | 69238-1373-2 |
| NDC Item | 69238137302 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1373-2) / 2.5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1373 |
NDC Item 69238137403
| NDC 9 | 69238-1374 |
|---|---|
| NDC 10 | 69238-1374-3 |
| NDC Item | 69238137403 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1374-3) / 5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1374 |
NDC Item 69238137506
| NDC 9 | 69238-1375 |
|---|---|
| NDC 10 | 69238-1375-6 |
| NDC Item | 69238137506 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1375-6) / 10 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1375 |
NDC Item 70518399400
| NDC 9 | 70518-3994 |
|---|---|
| NDC 10 | 70518-3994-0 |
| NDC Item | 70518399400 |
| Packaging | 5 mL in 1 BOTTLE (70518-3994-0) |
| FDA SPL set id | 766955 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2024-01-24 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 70518-3994 |
NDC Item 72162112802
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-2 |
| NDC Item | 72162112802 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (72162-1128-2) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112804
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-4 |
| NDC Item | 72162112804 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (72162-1128-4) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112807
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-7 |
| NDC Item | 72162112807 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (72162-1128-7) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 80425026001
| NDC 9 | 80425-0260 |
|---|---|
| NDC 10 | 80425-0260-1 |
| NDC Item | 80425026001 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (80425-0260-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 848958 |
| Labeler | Advanced Rx Pharmacy of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 80425-0260 |
NDC Item 80425036601
| NDC 9 | 80425-0366 |
|---|---|
| NDC 10 | 80425-0366-1 |
| NDC Item | 80425036601 |
| Packaging | 5 mL in 1 BOTTLE (80425-0366-1) |
| FDA SPL set id | 847557 |
| Labeler | Advanced Rx of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2023-11-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 80425-0366 |
NDC Item 00574403105
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-05 |
| NDC Item | 00574403105 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (0574-4031-05) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403110
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-10 |
| NDC Item | 00574403110 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (0574-4031-10) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403125
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-25 |
| NDC Item | 00574403125 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (0574-4031-25) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 24208029505
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-05 |
| NDC Item | 24208029505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029510
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-10 |
| NDC Item | 24208029510 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-10) / 10 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029525
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-25 |
| NDC Item | 24208029525 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-25) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 50090113500
| NDC 9 | 50090-1135 |
|---|---|
| NDC 10 | 50090-1135-0 |
| NDC Item | 50090113500 |
| Packaging | 2.5 mL in 1 BOTTLE (50090-1135-0) |
| FDA SPL set id | 718677 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1135 |
NDC Item 50090113600
| NDC 9 | 50090-1136 |
|---|---|
| NDC 10 | 50090-1136-0 |
| NDC Item | 50090113600 |
| Packaging | 5 mL in 1 BOTTLE (50090-1136-0) |
| FDA SPL set id | 803024 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1136 |
NDC Item 50090189300
| NDC 9 | 50090-1893 |
|---|---|
| NDC 10 | 50090-1893-0 |
| NDC Item | 50090189300 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1893-0) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 771442 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1893 |
NDC Item 50090191400
| NDC 9 | 50090-1914 |
|---|---|
| NDC 10 | 50090-1914-0 |
| NDC Item | 50090191400 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1914-0) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 693387 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1914 |
NDC Item 50090726700
| NDC 9 | 50090-7267 |
|---|---|
| NDC 10 | 50090-7267-0 |
| NDC Item | 50090726700 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (50090-7267-0) |
| ANDA | ANDA212715 |
| FDA SPL set id | 817223 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-7267 |
NDC Item 52959098401
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-01 |
| NDC Item | 52959098401 |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 52959098410
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-10 |
| NDC Item | 52959098410 |
| Packaging | 10 mL in 1 BOTTLE (52959-984-10) |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 55700091505
| NDC 9 | 55700-915 |
|---|---|
| NDC 10 | 55700-915-05 |
| NDC Item | 55700091505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (55700-915-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 653524 |
| Labeler | Quality Care Products, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55700-915 |
NDC Item 61314064705
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-05 |
| NDC Item | 61314064705 |
| Packaging | 5 mL in 1 BOTTLE (61314-647-05) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064710
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-10 |
| NDC Item | 61314064710 |
| Packaging | 10 mL in 1 BOTTLE (61314-647-10) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064725
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-25 |
| NDC Item | 61314064725 |
| Packaging | 2.5 mL in 1 BOTTLE (61314-647-25) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 63629957001
| NDC 9 | 63629-9570 |
|---|---|
| NDC 10 | 63629-9570-1 |
| NDC Item | 63629957001 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (63629-9570-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763323 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9570 |
NDC Item 63629957101
| NDC 9 | 63629-9571 |
|---|---|
| NDC 10 | 63629-9571-1 |
| NDC Item | 63629957101 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (63629-9571-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763569 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9571 |
NDC Item 63629957201
| NDC 9 | 63629-9572 |
|---|---|
| NDC 10 | 63629-9572-1 |
| NDC Item | 63629957201 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (63629-9572-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763269 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9572 |
NDC Item 67296066501
| NDC 9 | 67296-0665 |
|---|---|
| NDC 10 | 67296-0665-1 |
| NDC Item | 67296066501 |
| Packaging | 5 mL in 1 BOTTLE (67296-0665-1) |
| FDA SPL set id | 813479 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 67296-0665 |
NDC Item 68071182102
| NDC 9 | 68071-1821 |
|---|---|
| NDC 10 | 68071-1821-2 |
| NDC Item | 68071182102 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (68071-1821-2) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 858986 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-1821 |
NDC Item 68071420305
| NDC 9 | 68071-4203 |
|---|---|
| NDC 10 | 68071-4203-5 |
| NDC Item | 68071420305 |
| Packaging | 5 mL in 1 BOX (68071-4203-5) |
| ANDA | ANDA064134 |
| FDA SPL set id | 790175 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-4203 |
NDC Item 69238137302
| NDC 9 | 69238-1373 |
|---|---|
| NDC 10 | 69238-1373-2 |
| NDC Item | 69238137302 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1373-2) / 2.5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1373 |
NDC Item 69238137403
| NDC 9 | 69238-1374 |
|---|---|
| NDC 10 | 69238-1374-3 |
| NDC Item | 69238137403 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1374-3) / 5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1374 |
NDC Item 69238137506
| NDC 9 | 69238-1375 |
|---|---|
| NDC 10 | 69238-1375-6 |
| NDC Item | 69238137506 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1375-6) / 10 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1375 |
NDC Item 70518399400
| NDC 9 | 70518-3994 |
|---|---|
| NDC 10 | 70518-3994-0 |
| NDC Item | 70518399400 |
| Packaging | 5 mL in 1 BOTTLE (70518-3994-0) |
| FDA SPL set id | 766955 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2024-01-24 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 70518-3994 |
NDC Item 72162112802
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-2 |
| NDC Item | 72162112802 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (72162-1128-2) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112804
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-4 |
| NDC Item | 72162112804 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (72162-1128-4) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112807
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-7 |
| NDC Item | 72162112807 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (72162-1128-7) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 80425026001
| NDC 9 | 80425-0260 |
|---|---|
| NDC 10 | 80425-0260-1 |
| NDC Item | 80425026001 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (80425-0260-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 848958 |
| Labeler | Advanced Rx Pharmacy of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 80425-0260 |
NDC Item 80425036601
| NDC 9 | 80425-0366 |
|---|---|
| NDC 10 | 80425-0366-1 |
| NDC Item | 80425036601 |
| Packaging | 5 mL in 1 BOTTLE (80425-0366-1) |
| FDA SPL set id | 847557 |
| Labeler | Advanced Rx of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2023-11-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 80425-0366 |
NDC Item 00574403105
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-05 |
| NDC Item | 00574403105 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (0574-4031-05) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403110
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-10 |
| NDC Item | 00574403110 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (0574-4031-10) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403125
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-25 |
| NDC Item | 00574403125 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (0574-4031-25) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 24208029505
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-05 |
| NDC Item | 24208029505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029510
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-10 |
| NDC Item | 24208029510 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-10) / 10 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029525
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-25 |
| NDC Item | 24208029525 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-25) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 50090113500
| NDC 9 | 50090-1135 |
|---|---|
| NDC 10 | 50090-1135-0 |
| NDC Item | 50090113500 |
| Packaging | 2.5 mL in 1 BOTTLE (50090-1135-0) |
| FDA SPL set id | 718677 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1135 |
NDC Item 50090113600
| NDC 9 | 50090-1136 |
|---|---|
| NDC 10 | 50090-1136-0 |
| NDC Item | 50090113600 |
| Packaging | 5 mL in 1 BOTTLE (50090-1136-0) |
| FDA SPL set id | 803024 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1136 |
NDC Item 50090189300
| NDC 9 | 50090-1893 |
|---|---|
| NDC 10 | 50090-1893-0 |
| NDC Item | 50090189300 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1893-0) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 771442 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1893 |
NDC Item 50090191400
| NDC 9 | 50090-1914 |
|---|---|
| NDC 10 | 50090-1914-0 |
| NDC Item | 50090191400 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1914-0) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 693387 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1914 |
NDC Item 50090726700
| NDC 9 | 50090-7267 |
|---|---|
| NDC 10 | 50090-7267-0 |
| NDC Item | 50090726700 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (50090-7267-0) |
| ANDA | ANDA212715 |
| FDA SPL set id | 817223 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-7267 |
NDC Item 52959098401
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-01 |
| NDC Item | 52959098401 |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 52959098410
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-10 |
| NDC Item | 52959098410 |
| Packaging | 10 mL in 1 BOTTLE (52959-984-10) |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 55700091505
| NDC 9 | 55700-915 |
|---|---|
| NDC 10 | 55700-915-05 |
| NDC Item | 55700091505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (55700-915-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 653524 |
| Labeler | Quality Care Products, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55700-915 |
NDC Item 61314064705
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-05 |
| NDC Item | 61314064705 |
| Packaging | 5 mL in 1 BOTTLE (61314-647-05) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064710
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-10 |
| NDC Item | 61314064710 |
| Packaging | 10 mL in 1 BOTTLE (61314-647-10) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064725
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-25 |
| NDC Item | 61314064725 |
| Packaging | 2.5 mL in 1 BOTTLE (61314-647-25) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 63629957001
| NDC 9 | 63629-9570 |
|---|---|
| NDC 10 | 63629-9570-1 |
| NDC Item | 63629957001 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (63629-9570-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763323 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9570 |
NDC Item 63629957101
| NDC 9 | 63629-9571 |
|---|---|
| NDC 10 | 63629-9571-1 |
| NDC Item | 63629957101 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (63629-9571-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763569 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9571 |
NDC Item 63629957201
| NDC 9 | 63629-9572 |
|---|---|
| NDC 10 | 63629-9572-1 |
| NDC Item | 63629957201 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (63629-9572-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763269 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9572 |
NDC Item 67296066501
| NDC 9 | 67296-0665 |
|---|---|
| NDC 10 | 67296-0665-1 |
| NDC Item | 67296066501 |
| Packaging | 5 mL in 1 BOTTLE (67296-0665-1) |
| FDA SPL set id | 813479 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 67296-0665 |
NDC Item 68071182102
| NDC 9 | 68071-1821 |
|---|---|
| NDC 10 | 68071-1821-2 |
| NDC Item | 68071182102 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (68071-1821-2) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 858986 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-1821 |
NDC Item 68071420305
| NDC 9 | 68071-4203 |
|---|---|
| NDC 10 | 68071-4203-5 |
| NDC Item | 68071420305 |
| Packaging | 5 mL in 1 BOX (68071-4203-5) |
| ANDA | ANDA064134 |
| FDA SPL set id | 790175 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-4203 |
NDC Item 69238137302
| NDC 9 | 69238-1373 |
|---|---|
| NDC 10 | 69238-1373-2 |
| NDC Item | 69238137302 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1373-2) / 2.5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1373 |
NDC Item 69238137403
| NDC 9 | 69238-1374 |
|---|---|
| NDC 10 | 69238-1374-3 |
| NDC Item | 69238137403 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1374-3) / 5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1374 |
NDC Item 69238137506
| NDC 9 | 69238-1375 |
|---|---|
| NDC 10 | 69238-1375-6 |
| NDC Item | 69238137506 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1375-6) / 10 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1375 |
NDC Item 70518399400
| NDC 9 | 70518-3994 |
|---|---|
| NDC 10 | 70518-3994-0 |
| NDC Item | 70518399400 |
| Packaging | 5 mL in 1 BOTTLE (70518-3994-0) |
| FDA SPL set id | 766955 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2024-01-24 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 70518-3994 |
NDC Item 72162112802
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-2 |
| NDC Item | 72162112802 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (72162-1128-2) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112804
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-4 |
| NDC Item | 72162112804 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (72162-1128-4) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112807
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-7 |
| NDC Item | 72162112807 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (72162-1128-7) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 80425026001
| NDC 9 | 80425-0260 |
|---|---|
| NDC 10 | 80425-0260-1 |
| NDC Item | 80425026001 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (80425-0260-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 848958 |
| Labeler | Advanced Rx Pharmacy of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 80425-0260 |
NDC Item 80425036601
| NDC 9 | 80425-0366 |
|---|---|
| NDC 10 | 80425-0366-1 |
| NDC Item | 80425036601 |
| Packaging | 5 mL in 1 BOTTLE (80425-0366-1) |
| FDA SPL set id | 847557 |
| Labeler | Advanced Rx of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2023-11-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 80425-0366 |
NDC Item 00574403105
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-05 |
| NDC Item | 00574403105 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (0574-4031-05) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403110
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-10 |
| NDC Item | 00574403110 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (0574-4031-10) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403125
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-25 |
| NDC Item | 00574403125 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (0574-4031-25) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 24208029505
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-05 |
| NDC Item | 24208029505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029510
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-10 |
| NDC Item | 24208029510 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-10) / 10 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029525
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-25 |
| NDC Item | 24208029525 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-25) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 50090113500
| NDC 9 | 50090-1135 |
|---|---|
| NDC 10 | 50090-1135-0 |
| NDC Item | 50090113500 |
| Packaging | 2.5 mL in 1 BOTTLE (50090-1135-0) |
| FDA SPL set id | 718677 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1135 |
NDC Item 50090113600
| NDC 9 | 50090-1136 |
|---|---|
| NDC 10 | 50090-1136-0 |
| NDC Item | 50090113600 |
| Packaging | 5 mL in 1 BOTTLE (50090-1136-0) |
| FDA SPL set id | 803024 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1136 |
NDC Item 50090189300
| NDC 9 | 50090-1893 |
|---|---|
| NDC 10 | 50090-1893-0 |
| NDC Item | 50090189300 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1893-0) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 771442 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1893 |
NDC Item 50090191400
| NDC 9 | 50090-1914 |
|---|---|
| NDC 10 | 50090-1914-0 |
| NDC Item | 50090191400 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1914-0) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 693387 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1914 |
NDC Item 50090726700
| NDC 9 | 50090-7267 |
|---|---|
| NDC 10 | 50090-7267-0 |
| NDC Item | 50090726700 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (50090-7267-0) |
| ANDA | ANDA212715 |
| FDA SPL set id | 817223 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-7267 |
NDC Item 52959098401
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-01 |
| NDC Item | 52959098401 |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 52959098410
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-10 |
| NDC Item | 52959098410 |
| Packaging | 10 mL in 1 BOTTLE (52959-984-10) |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 55700091505
| NDC 9 | 55700-915 |
|---|---|
| NDC 10 | 55700-915-05 |
| NDC Item | 55700091505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (55700-915-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 653524 |
| Labeler | Quality Care Products, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55700-915 |
NDC Item 61314064705
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-05 |
| NDC Item | 61314064705 |
| Packaging | 5 mL in 1 BOTTLE (61314-647-05) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064710
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-10 |
| NDC Item | 61314064710 |
| Packaging | 10 mL in 1 BOTTLE (61314-647-10) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064725
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-25 |
| NDC Item | 61314064725 |
| Packaging | 2.5 mL in 1 BOTTLE (61314-647-25) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 63629957001
| NDC 9 | 63629-9570 |
|---|---|
| NDC 10 | 63629-9570-1 |
| NDC Item | 63629957001 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (63629-9570-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763323 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9570 |
NDC Item 63629957101
| NDC 9 | 63629-9571 |
|---|---|
| NDC 10 | 63629-9571-1 |
| NDC Item | 63629957101 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (63629-9571-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763569 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9571 |
NDC Item 63629957201
| NDC 9 | 63629-9572 |
|---|---|
| NDC 10 | 63629-9572-1 |
| NDC Item | 63629957201 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (63629-9572-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763269 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9572 |
NDC Item 67296066501
| NDC 9 | 67296-0665 |
|---|---|
| NDC 10 | 67296-0665-1 |
| NDC Item | 67296066501 |
| Packaging | 5 mL in 1 BOTTLE (67296-0665-1) |
| FDA SPL set id | 813479 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 67296-0665 |
NDC Item 68071182102
| NDC 9 | 68071-1821 |
|---|---|
| NDC 10 | 68071-1821-2 |
| NDC Item | 68071182102 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (68071-1821-2) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 858986 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-1821 |
NDC Item 68071420305
| NDC 9 | 68071-4203 |
|---|---|
| NDC 10 | 68071-4203-5 |
| NDC Item | 68071420305 |
| Packaging | 5 mL in 1 BOX (68071-4203-5) |
| ANDA | ANDA064134 |
| FDA SPL set id | 790175 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-4203 |
NDC Item 69238137302
| NDC 9 | 69238-1373 |
|---|---|
| NDC 10 | 69238-1373-2 |
| NDC Item | 69238137302 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1373-2) / 2.5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1373 |
NDC Item 69238137403
| NDC 9 | 69238-1374 |
|---|---|
| NDC 10 | 69238-1374-3 |
| NDC Item | 69238137403 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1374-3) / 5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1374 |
NDC Item 69238137506
| NDC 9 | 69238-1375 |
|---|---|
| NDC 10 | 69238-1375-6 |
| NDC Item | 69238137506 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1375-6) / 10 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1375 |
NDC Item 70518399400
| NDC 9 | 70518-3994 |
|---|---|
| NDC 10 | 70518-3994-0 |
| NDC Item | 70518399400 |
| Packaging | 5 mL in 1 BOTTLE (70518-3994-0) |
| FDA SPL set id | 766955 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2024-01-24 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 70518-3994 |
NDC Item 72162112802
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-2 |
| NDC Item | 72162112802 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (72162-1128-2) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112804
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-4 |
| NDC Item | 72162112804 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (72162-1128-4) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112807
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-7 |
| NDC Item | 72162112807 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (72162-1128-7) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 80425026001
| NDC 9 | 80425-0260 |
|---|---|
| NDC 10 | 80425-0260-1 |
| NDC Item | 80425026001 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (80425-0260-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 848958 |
| Labeler | Advanced Rx Pharmacy of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 80425-0260 |
NDC Item 80425036601
| NDC 9 | 80425-0366 |
|---|---|
| NDC 10 | 80425-0366-1 |
| NDC Item | 80425036601 |
| Packaging | 5 mL in 1 BOTTLE (80425-0366-1) |
| FDA SPL set id | 847557 |
| Labeler | Advanced Rx of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2023-11-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 80425-0366 |
NDC Item 00574403105
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-05 |
| NDC Item | 00574403105 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (0574-4031-05) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403110
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-10 |
| NDC Item | 00574403110 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (0574-4031-10) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403125
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-25 |
| NDC Item | 00574403125 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (0574-4031-25) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 24208029505
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-05 |
| NDC Item | 24208029505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029510
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-10 |
| NDC Item | 24208029510 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-10) / 10 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029525
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-25 |
| NDC Item | 24208029525 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-25) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 50090113500
| NDC 9 | 50090-1135 |
|---|---|
| NDC 10 | 50090-1135-0 |
| NDC Item | 50090113500 |
| Packaging | 2.5 mL in 1 BOTTLE (50090-1135-0) |
| FDA SPL set id | 718677 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1135 |
NDC Item 50090113600
| NDC 9 | 50090-1136 |
|---|---|
| NDC 10 | 50090-1136-0 |
| NDC Item | 50090113600 |
| Packaging | 5 mL in 1 BOTTLE (50090-1136-0) |
| FDA SPL set id | 803024 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1136 |
NDC Item 50090189300
| NDC 9 | 50090-1893 |
|---|---|
| NDC 10 | 50090-1893-0 |
| NDC Item | 50090189300 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1893-0) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 771442 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1893 |
NDC Item 50090191400
| NDC 9 | 50090-1914 |
|---|---|
| NDC 10 | 50090-1914-0 |
| NDC Item | 50090191400 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1914-0) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 693387 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1914 |
NDC Item 50090726700
| NDC 9 | 50090-7267 |
|---|---|
| NDC 10 | 50090-7267-0 |
| NDC Item | 50090726700 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (50090-7267-0) |
| ANDA | ANDA212715 |
| FDA SPL set id | 817223 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-7267 |
NDC Item 52959098401
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-01 |
| NDC Item | 52959098401 |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 52959098410
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-10 |
| NDC Item | 52959098410 |
| Packaging | 10 mL in 1 BOTTLE (52959-984-10) |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 55700091505
| NDC 9 | 55700-915 |
|---|---|
| NDC 10 | 55700-915-05 |
| NDC Item | 55700091505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (55700-915-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 653524 |
| Labeler | Quality Care Products, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55700-915 |
NDC Item 61314064705
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-05 |
| NDC Item | 61314064705 |
| Packaging | 5 mL in 1 BOTTLE (61314-647-05) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064710
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-10 |
| NDC Item | 61314064710 |
| Packaging | 10 mL in 1 BOTTLE (61314-647-10) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064725
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-25 |
| NDC Item | 61314064725 |
| Packaging | 2.5 mL in 1 BOTTLE (61314-647-25) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 63629957001
| NDC 9 | 63629-9570 |
|---|---|
| NDC 10 | 63629-9570-1 |
| NDC Item | 63629957001 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (63629-9570-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763323 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9570 |
NDC Item 63629957101
| NDC 9 | 63629-9571 |
|---|---|
| NDC 10 | 63629-9571-1 |
| NDC Item | 63629957101 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (63629-9571-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763569 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9571 |
NDC Item 63629957201
| NDC 9 | 63629-9572 |
|---|---|
| NDC 10 | 63629-9572-1 |
| NDC Item | 63629957201 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (63629-9572-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763269 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9572 |
NDC Item 67296066501
| NDC 9 | 67296-0665 |
|---|---|
| NDC 10 | 67296-0665-1 |
| NDC Item | 67296066501 |
| Packaging | 5 mL in 1 BOTTLE (67296-0665-1) |
| FDA SPL set id | 813479 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 67296-0665 |
NDC Item 68071182102
| NDC 9 | 68071-1821 |
|---|---|
| NDC 10 | 68071-1821-2 |
| NDC Item | 68071182102 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (68071-1821-2) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 858986 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-1821 |
NDC Item 68071420305
| NDC 9 | 68071-4203 |
|---|---|
| NDC 10 | 68071-4203-5 |
| NDC Item | 68071420305 |
| Packaging | 5 mL in 1 BOX (68071-4203-5) |
| ANDA | ANDA064134 |
| FDA SPL set id | 790175 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-4203 |
NDC Item 69238137302
| NDC 9 | 69238-1373 |
|---|---|
| NDC 10 | 69238-1373-2 |
| NDC Item | 69238137302 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1373-2) / 2.5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1373 |
NDC Item 69238137403
| NDC 9 | 69238-1374 |
|---|---|
| NDC 10 | 69238-1374-3 |
| NDC Item | 69238137403 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1374-3) / 5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1374 |
NDC Item 69238137506
| NDC 9 | 69238-1375 |
|---|---|
| NDC 10 | 69238-1375-6 |
| NDC Item | 69238137506 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1375-6) / 10 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1375 |
NDC Item 70518399400
| NDC 9 | 70518-3994 |
|---|---|
| NDC 10 | 70518-3994-0 |
| NDC Item | 70518399400 |
| Packaging | 5 mL in 1 BOTTLE (70518-3994-0) |
| FDA SPL set id | 766955 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2024-01-24 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 70518-3994 |
NDC Item 72162112802
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-2 |
| NDC Item | 72162112802 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (72162-1128-2) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112804
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-4 |
| NDC Item | 72162112804 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (72162-1128-4) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112807
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-7 |
| NDC Item | 72162112807 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (72162-1128-7) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 80425026001
| NDC 9 | 80425-0260 |
|---|---|
| NDC 10 | 80425-0260-1 |
| NDC Item | 80425026001 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (80425-0260-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 848958 |
| Labeler | Advanced Rx Pharmacy of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 80425-0260 |
NDC Item 80425036601
| NDC 9 | 80425-0366 |
|---|---|
| NDC 10 | 80425-0366-1 |
| NDC Item | 80425036601 |
| Packaging | 5 mL in 1 BOTTLE (80425-0366-1) |
| FDA SPL set id | 847557 |
| Labeler | Advanced Rx of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2023-11-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 80425-0366 |
NDC Item 00574403105
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-05 |
| NDC Item | 00574403105 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (0574-4031-05) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403110
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-10 |
| NDC Item | 00574403110 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (0574-4031-10) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403125
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-25 |
| NDC Item | 00574403125 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (0574-4031-25) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 24208029505
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-05 |
| NDC Item | 24208029505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029510
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-10 |
| NDC Item | 24208029510 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-10) / 10 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029525
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-25 |
| NDC Item | 24208029525 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-25) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 50090113500
| NDC 9 | 50090-1135 |
|---|---|
| NDC 10 | 50090-1135-0 |
| NDC Item | 50090113500 |
| Packaging | 2.5 mL in 1 BOTTLE (50090-1135-0) |
| FDA SPL set id | 718677 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1135 |
NDC Item 50090113600
| NDC 9 | 50090-1136 |
|---|---|
| NDC 10 | 50090-1136-0 |
| NDC Item | 50090113600 |
| Packaging | 5 mL in 1 BOTTLE (50090-1136-0) |
| FDA SPL set id | 803024 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1136 |
NDC Item 50090189300
| NDC 9 | 50090-1893 |
|---|---|
| NDC 10 | 50090-1893-0 |
| NDC Item | 50090189300 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1893-0) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 771442 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1893 |
NDC Item 50090191400
| NDC 9 | 50090-1914 |
|---|---|
| NDC 10 | 50090-1914-0 |
| NDC Item | 50090191400 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1914-0) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 693387 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1914 |
NDC Item 50090726700
| NDC 9 | 50090-7267 |
|---|---|
| NDC 10 | 50090-7267-0 |
| NDC Item | 50090726700 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (50090-7267-0) |
| ANDA | ANDA212715 |
| FDA SPL set id | 817223 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-7267 |
NDC Item 52959098401
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-01 |
| NDC Item | 52959098401 |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 52959098410
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-10 |
| NDC Item | 52959098410 |
| Packaging | 10 mL in 1 BOTTLE (52959-984-10) |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 55700091505
| NDC 9 | 55700-915 |
|---|---|
| NDC 10 | 55700-915-05 |
| NDC Item | 55700091505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (55700-915-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 653524 |
| Labeler | Quality Care Products, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55700-915 |
NDC Item 61314064705
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-05 |
| NDC Item | 61314064705 |
| Packaging | 5 mL in 1 BOTTLE (61314-647-05) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064710
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-10 |
| NDC Item | 61314064710 |
| Packaging | 10 mL in 1 BOTTLE (61314-647-10) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064725
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-25 |
| NDC Item | 61314064725 |
| Packaging | 2.5 mL in 1 BOTTLE (61314-647-25) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 63629957001
| NDC 9 | 63629-9570 |
|---|---|
| NDC 10 | 63629-9570-1 |
| NDC Item | 63629957001 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (63629-9570-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763323 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9570 |
NDC Item 63629957101
| NDC 9 | 63629-9571 |
|---|---|
| NDC 10 | 63629-9571-1 |
| NDC Item | 63629957101 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (63629-9571-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763569 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9571 |
NDC Item 63629957201
| NDC 9 | 63629-9572 |
|---|---|
| NDC 10 | 63629-9572-1 |
| NDC Item | 63629957201 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (63629-9572-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763269 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9572 |
NDC Item 67296066501
| NDC 9 | 67296-0665 |
|---|---|
| NDC 10 | 67296-0665-1 |
| NDC Item | 67296066501 |
| Packaging | 5 mL in 1 BOTTLE (67296-0665-1) |
| FDA SPL set id | 813479 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 67296-0665 |
NDC Item 68071182102
| NDC 9 | 68071-1821 |
|---|---|
| NDC 10 | 68071-1821-2 |
| NDC Item | 68071182102 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (68071-1821-2) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 858986 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-1821 |
NDC Item 68071420305
| NDC 9 | 68071-4203 |
|---|---|
| NDC 10 | 68071-4203-5 |
| NDC Item | 68071420305 |
| Packaging | 5 mL in 1 BOX (68071-4203-5) |
| ANDA | ANDA064134 |
| FDA SPL set id | 790175 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-4203 |
NDC Item 69238137302
| NDC 9 | 69238-1373 |
|---|---|
| NDC 10 | 69238-1373-2 |
| NDC Item | 69238137302 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1373-2) / 2.5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1373 |
NDC Item 69238137403
| NDC 9 | 69238-1374 |
|---|---|
| NDC 10 | 69238-1374-3 |
| NDC Item | 69238137403 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1374-3) / 5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1374 |
NDC Item 69238137506
| NDC 9 | 69238-1375 |
|---|---|
| NDC 10 | 69238-1375-6 |
| NDC Item | 69238137506 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1375-6) / 10 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1375 |
NDC Item 70518399400
| NDC 9 | 70518-3994 |
|---|---|
| NDC 10 | 70518-3994-0 |
| NDC Item | 70518399400 |
| Packaging | 5 mL in 1 BOTTLE (70518-3994-0) |
| FDA SPL set id | 766955 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2024-01-24 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 70518-3994 |
NDC Item 72162112802
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-2 |
| NDC Item | 72162112802 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (72162-1128-2) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112804
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-4 |
| NDC Item | 72162112804 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (72162-1128-4) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112807
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-7 |
| NDC Item | 72162112807 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (72162-1128-7) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 80425026001
| NDC 9 | 80425-0260 |
|---|---|
| NDC 10 | 80425-0260-1 |
| NDC Item | 80425026001 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (80425-0260-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 848958 |
| Labeler | Advanced Rx Pharmacy of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 80425-0260 |
NDC Item 80425036601
| NDC 9 | 80425-0366 |
|---|---|
| NDC 10 | 80425-0366-1 |
| NDC Item | 80425036601 |
| Packaging | 5 mL in 1 BOTTLE (80425-0366-1) |
| FDA SPL set id | 847557 |
| Labeler | Advanced Rx of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2023-11-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 80425-0366 |
NDC Item 00574403105
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-05 |
| NDC Item | 00574403105 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (0574-4031-05) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403110
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-10 |
| NDC Item | 00574403110 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (0574-4031-10) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403125
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-25 |
| NDC Item | 00574403125 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (0574-4031-25) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 24208029505
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-05 |
| NDC Item | 24208029505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029510
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-10 |
| NDC Item | 24208029510 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-10) / 10 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029525
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-25 |
| NDC Item | 24208029525 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-25) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 50090113500
| NDC 9 | 50090-1135 |
|---|---|
| NDC 10 | 50090-1135-0 |
| NDC Item | 50090113500 |
| Packaging | 2.5 mL in 1 BOTTLE (50090-1135-0) |
| FDA SPL set id | 718677 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1135 |
NDC Item 50090113600
| NDC 9 | 50090-1136 |
|---|---|
| NDC 10 | 50090-1136-0 |
| NDC Item | 50090113600 |
| Packaging | 5 mL in 1 BOTTLE (50090-1136-0) |
| FDA SPL set id | 803024 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1136 |
NDC Item 50090189300
| NDC 9 | 50090-1893 |
|---|---|
| NDC 10 | 50090-1893-0 |
| NDC Item | 50090189300 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1893-0) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 771442 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1893 |
NDC Item 50090191400
| NDC 9 | 50090-1914 |
|---|---|
| NDC 10 | 50090-1914-0 |
| NDC Item | 50090191400 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1914-0) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 693387 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1914 |
NDC Item 50090726700
| NDC 9 | 50090-7267 |
|---|---|
| NDC 10 | 50090-7267-0 |
| NDC Item | 50090726700 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (50090-7267-0) |
| ANDA | ANDA212715 |
| FDA SPL set id | 817223 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-7267 |
NDC Item 52959098401
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-01 |
| NDC Item | 52959098401 |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 52959098410
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-10 |
| NDC Item | 52959098410 |
| Packaging | 10 mL in 1 BOTTLE (52959-984-10) |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 55700091505
| NDC 9 | 55700-915 |
|---|---|
| NDC 10 | 55700-915-05 |
| NDC Item | 55700091505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (55700-915-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 653524 |
| Labeler | Quality Care Products, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55700-915 |
NDC Item 61314064705
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-05 |
| NDC Item | 61314064705 |
| Packaging | 5 mL in 1 BOTTLE (61314-647-05) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064710
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-10 |
| NDC Item | 61314064710 |
| Packaging | 10 mL in 1 BOTTLE (61314-647-10) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064725
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-25 |
| NDC Item | 61314064725 |
| Packaging | 2.5 mL in 1 BOTTLE (61314-647-25) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 63629957001
| NDC 9 | 63629-9570 |
|---|---|
| NDC 10 | 63629-9570-1 |
| NDC Item | 63629957001 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (63629-9570-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763323 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9570 |
NDC Item 63629957101
| NDC 9 | 63629-9571 |
|---|---|
| NDC 10 | 63629-9571-1 |
| NDC Item | 63629957101 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (63629-9571-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763569 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9571 |
NDC Item 63629957201
| NDC 9 | 63629-9572 |
|---|---|
| NDC 10 | 63629-9572-1 |
| NDC Item | 63629957201 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (63629-9572-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763269 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9572 |
NDC Item 67296066501
| NDC 9 | 67296-0665 |
|---|---|
| NDC 10 | 67296-0665-1 |
| NDC Item | 67296066501 |
| Packaging | 5 mL in 1 BOTTLE (67296-0665-1) |
| FDA SPL set id | 813479 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 67296-0665 |
NDC Item 68071182102
| NDC 9 | 68071-1821 |
|---|---|
| NDC 10 | 68071-1821-2 |
| NDC Item | 68071182102 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (68071-1821-2) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 858986 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-1821 |
NDC Item 68071420305
| NDC 9 | 68071-4203 |
|---|---|
| NDC 10 | 68071-4203-5 |
| NDC Item | 68071420305 |
| Packaging | 5 mL in 1 BOX (68071-4203-5) |
| ANDA | ANDA064134 |
| FDA SPL set id | 790175 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-4203 |
NDC Item 69238137302
| NDC 9 | 69238-1373 |
|---|---|
| NDC 10 | 69238-1373-2 |
| NDC Item | 69238137302 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1373-2) / 2.5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1373 |
NDC Item 69238137403
| NDC 9 | 69238-1374 |
|---|---|
| NDC 10 | 69238-1374-3 |
| NDC Item | 69238137403 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1374-3) / 5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1374 |
NDC Item 69238137506
| NDC 9 | 69238-1375 |
|---|---|
| NDC 10 | 69238-1375-6 |
| NDC Item | 69238137506 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1375-6) / 10 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1375 |
NDC Item 70518399400
| NDC 9 | 70518-3994 |
|---|---|
| NDC 10 | 70518-3994-0 |
| NDC Item | 70518399400 |
| Packaging | 5 mL in 1 BOTTLE (70518-3994-0) |
| FDA SPL set id | 766955 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2024-01-24 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 70518-3994 |
NDC Item 72162112802
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-2 |
| NDC Item | 72162112802 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (72162-1128-2) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112804
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-4 |
| NDC Item | 72162112804 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (72162-1128-4) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112807
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-7 |
| NDC Item | 72162112807 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (72162-1128-7) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 80425026001
| NDC 9 | 80425-0260 |
|---|---|
| NDC 10 | 80425-0260-1 |
| NDC Item | 80425026001 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (80425-0260-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 848958 |
| Labeler | Advanced Rx Pharmacy of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 80425-0260 |
NDC Item 80425036601
| NDC 9 | 80425-0366 |
|---|---|
| NDC 10 | 80425-0366-1 |
| NDC Item | 80425036601 |
| Packaging | 5 mL in 1 BOTTLE (80425-0366-1) |
| FDA SPL set id | 847557 |
| Labeler | Advanced Rx of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2023-11-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 80425-0366 |
NDC Item 00574403105
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-05 |
| NDC Item | 00574403105 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (0574-4031-05) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403110
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-10 |
| NDC Item | 00574403110 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (0574-4031-10) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403125
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-25 |
| NDC Item | 00574403125 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (0574-4031-25) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 24208029505
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-05 |
| NDC Item | 24208029505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029510
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-10 |
| NDC Item | 24208029510 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-10) / 10 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029525
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-25 |
| NDC Item | 24208029525 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-25) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 50090113500
| NDC 9 | 50090-1135 |
|---|---|
| NDC 10 | 50090-1135-0 |
| NDC Item | 50090113500 |
| Packaging | 2.5 mL in 1 BOTTLE (50090-1135-0) |
| FDA SPL set id | 718677 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1135 |
NDC Item 50090113600
| NDC 9 | 50090-1136 |
|---|---|
| NDC 10 | 50090-1136-0 |
| NDC Item | 50090113600 |
| Packaging | 5 mL in 1 BOTTLE (50090-1136-0) |
| FDA SPL set id | 803024 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1136 |
NDC Item 50090189300
| NDC 9 | 50090-1893 |
|---|---|
| NDC 10 | 50090-1893-0 |
| NDC Item | 50090189300 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1893-0) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 771442 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1893 |
NDC Item 50090191400
| NDC 9 | 50090-1914 |
|---|---|
| NDC 10 | 50090-1914-0 |
| NDC Item | 50090191400 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1914-0) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 693387 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1914 |
NDC Item 50090726700
| NDC 9 | 50090-7267 |
|---|---|
| NDC 10 | 50090-7267-0 |
| NDC Item | 50090726700 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (50090-7267-0) |
| ANDA | ANDA212715 |
| FDA SPL set id | 817223 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-7267 |
NDC Item 52959098401
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-01 |
| NDC Item | 52959098401 |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 52959098410
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-10 |
| NDC Item | 52959098410 |
| Packaging | 10 mL in 1 BOTTLE (52959-984-10) |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 55700091505
| NDC 9 | 55700-915 |
|---|---|
| NDC 10 | 55700-915-05 |
| NDC Item | 55700091505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (55700-915-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 653524 |
| Labeler | Quality Care Products, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55700-915 |
NDC Item 61314064705
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-05 |
| NDC Item | 61314064705 |
| Packaging | 5 mL in 1 BOTTLE (61314-647-05) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064710
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-10 |
| NDC Item | 61314064710 |
| Packaging | 10 mL in 1 BOTTLE (61314-647-10) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064725
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-25 |
| NDC Item | 61314064725 |
| Packaging | 2.5 mL in 1 BOTTLE (61314-647-25) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 63629957001
| NDC 9 | 63629-9570 |
|---|---|
| NDC 10 | 63629-9570-1 |
| NDC Item | 63629957001 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (63629-9570-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763323 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9570 |
NDC Item 63629957101
| NDC 9 | 63629-9571 |
|---|---|
| NDC 10 | 63629-9571-1 |
| NDC Item | 63629957101 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (63629-9571-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763569 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9571 |
NDC Item 63629957201
| NDC 9 | 63629-9572 |
|---|---|
| NDC 10 | 63629-9572-1 |
| NDC Item | 63629957201 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (63629-9572-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763269 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9572 |
NDC Item 67296066501
| NDC 9 | 67296-0665 |
|---|---|
| NDC 10 | 67296-0665-1 |
| NDC Item | 67296066501 |
| Packaging | 5 mL in 1 BOTTLE (67296-0665-1) |
| FDA SPL set id | 813479 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 67296-0665 |
NDC Item 68071182102
| NDC 9 | 68071-1821 |
|---|---|
| NDC 10 | 68071-1821-2 |
| NDC Item | 68071182102 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (68071-1821-2) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 858986 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-1821 |
NDC Item 68071420305
| NDC 9 | 68071-4203 |
|---|---|
| NDC 10 | 68071-4203-5 |
| NDC Item | 68071420305 |
| Packaging | 5 mL in 1 BOX (68071-4203-5) |
| ANDA | ANDA064134 |
| FDA SPL set id | 790175 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-4203 |
NDC Item 69238137302
| NDC 9 | 69238-1373 |
|---|---|
| NDC 10 | 69238-1373-2 |
| NDC Item | 69238137302 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1373-2) / 2.5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1373 |
NDC Item 69238137403
| NDC 9 | 69238-1374 |
|---|---|
| NDC 10 | 69238-1374-3 |
| NDC Item | 69238137403 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1374-3) / 5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1374 |
NDC Item 69238137506
| NDC 9 | 69238-1375 |
|---|---|
| NDC 10 | 69238-1375-6 |
| NDC Item | 69238137506 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1375-6) / 10 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1375 |
NDC Item 70518399400
| NDC 9 | 70518-3994 |
|---|---|
| NDC 10 | 70518-3994-0 |
| NDC Item | 70518399400 |
| Packaging | 5 mL in 1 BOTTLE (70518-3994-0) |
| FDA SPL set id | 766955 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2024-01-24 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 70518-3994 |
NDC Item 72162112802
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-2 |
| NDC Item | 72162112802 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (72162-1128-2) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112804
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-4 |
| NDC Item | 72162112804 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (72162-1128-4) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112807
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-7 |
| NDC Item | 72162112807 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (72162-1128-7) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 80425026001
| NDC 9 | 80425-0260 |
|---|---|
| NDC 10 | 80425-0260-1 |
| NDC Item | 80425026001 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (80425-0260-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 848958 |
| Labeler | Advanced Rx Pharmacy of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 80425-0260 |
NDC Item 80425036601
| NDC 9 | 80425-0366 |
|---|---|
| NDC 10 | 80425-0366-1 |
| NDC Item | 80425036601 |
| Packaging | 5 mL in 1 BOTTLE (80425-0366-1) |
| FDA SPL set id | 847557 |
| Labeler | Advanced Rx of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2023-11-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 80425-0366 |
NDC Item 00574403105
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-05 |
| NDC Item | 00574403105 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (0574-4031-05) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403110
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-10 |
| NDC Item | 00574403110 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (0574-4031-10) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403125
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-25 |
| NDC Item | 00574403125 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (0574-4031-25) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 24208029505
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-05 |
| NDC Item | 24208029505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029510
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-10 |
| NDC Item | 24208029510 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-10) / 10 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029525
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-25 |
| NDC Item | 24208029525 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-25) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 50090113500
| NDC 9 | 50090-1135 |
|---|---|
| NDC 10 | 50090-1135-0 |
| NDC Item | 50090113500 |
| Packaging | 2.5 mL in 1 BOTTLE (50090-1135-0) |
| FDA SPL set id | 718677 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1135 |
NDC Item 50090113600
| NDC 9 | 50090-1136 |
|---|---|
| NDC 10 | 50090-1136-0 |
| NDC Item | 50090113600 |
| Packaging | 5 mL in 1 BOTTLE (50090-1136-0) |
| FDA SPL set id | 803024 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1136 |
NDC Item 50090189300
| NDC 9 | 50090-1893 |
|---|---|
| NDC 10 | 50090-1893-0 |
| NDC Item | 50090189300 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1893-0) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 771442 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1893 |
NDC Item 50090191400
| NDC 9 | 50090-1914 |
|---|---|
| NDC 10 | 50090-1914-0 |
| NDC Item | 50090191400 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1914-0) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 693387 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1914 |
NDC Item 50090726700
| NDC 9 | 50090-7267 |
|---|---|
| NDC 10 | 50090-7267-0 |
| NDC Item | 50090726700 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (50090-7267-0) |
| ANDA | ANDA212715 |
| FDA SPL set id | 817223 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-7267 |
NDC Item 52959098401
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-01 |
| NDC Item | 52959098401 |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 52959098410
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-10 |
| NDC Item | 52959098410 |
| Packaging | 10 mL in 1 BOTTLE (52959-984-10) |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 55700091505
| NDC 9 | 55700-915 |
|---|---|
| NDC 10 | 55700-915-05 |
| NDC Item | 55700091505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (55700-915-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 653524 |
| Labeler | Quality Care Products, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55700-915 |
NDC Item 61314064705
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-05 |
| NDC Item | 61314064705 |
| Packaging | 5 mL in 1 BOTTLE (61314-647-05) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064710
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-10 |
| NDC Item | 61314064710 |
| Packaging | 10 mL in 1 BOTTLE (61314-647-10) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064725
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-25 |
| NDC Item | 61314064725 |
| Packaging | 2.5 mL in 1 BOTTLE (61314-647-25) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 63629957001
| NDC 9 | 63629-9570 |
|---|---|
| NDC 10 | 63629-9570-1 |
| NDC Item | 63629957001 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (63629-9570-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763323 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9570 |
NDC Item 63629957101
| NDC 9 | 63629-9571 |
|---|---|
| NDC 10 | 63629-9571-1 |
| NDC Item | 63629957101 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (63629-9571-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763569 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9571 |
NDC Item 63629957201
| NDC 9 | 63629-9572 |
|---|---|
| NDC 10 | 63629-9572-1 |
| NDC Item | 63629957201 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (63629-9572-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763269 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9572 |
NDC Item 67296066501
| NDC 9 | 67296-0665 |
|---|---|
| NDC 10 | 67296-0665-1 |
| NDC Item | 67296066501 |
| Packaging | 5 mL in 1 BOTTLE (67296-0665-1) |
| FDA SPL set id | 813479 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 67296-0665 |
NDC Item 68071182102
| NDC 9 | 68071-1821 |
|---|---|
| NDC 10 | 68071-1821-2 |
| NDC Item | 68071182102 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (68071-1821-2) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 858986 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-1821 |
NDC Item 68071420305
| NDC 9 | 68071-4203 |
|---|---|
| NDC 10 | 68071-4203-5 |
| NDC Item | 68071420305 |
| Packaging | 5 mL in 1 BOX (68071-4203-5) |
| ANDA | ANDA064134 |
| FDA SPL set id | 790175 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-4203 |
NDC Item 69238137302
| NDC 9 | 69238-1373 |
|---|---|
| NDC 10 | 69238-1373-2 |
| NDC Item | 69238137302 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1373-2) / 2.5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1373 |
NDC Item 69238137403
| NDC 9 | 69238-1374 |
|---|---|
| NDC 10 | 69238-1374-3 |
| NDC Item | 69238137403 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1374-3) / 5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1374 |
NDC Item 69238137506
| NDC 9 | 69238-1375 |
|---|---|
| NDC 10 | 69238-1375-6 |
| NDC Item | 69238137506 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1375-6) / 10 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1375 |
NDC Item 70518399400
| NDC 9 | 70518-3994 |
|---|---|
| NDC 10 | 70518-3994-0 |
| NDC Item | 70518399400 |
| Packaging | 5 mL in 1 BOTTLE (70518-3994-0) |
| FDA SPL set id | 766955 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2024-01-24 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 70518-3994 |
NDC Item 72162112802
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-2 |
| NDC Item | 72162112802 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (72162-1128-2) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112804
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-4 |
| NDC Item | 72162112804 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (72162-1128-4) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112807
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-7 |
| NDC Item | 72162112807 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (72162-1128-7) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 80425026001
| NDC 9 | 80425-0260 |
|---|---|
| NDC 10 | 80425-0260-1 |
| NDC Item | 80425026001 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (80425-0260-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 848958 |
| Labeler | Advanced Rx Pharmacy of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 80425-0260 |
NDC Item 80425036601
| NDC 9 | 80425-0366 |
|---|---|
| NDC 10 | 80425-0366-1 |
| NDC Item | 80425036601 |
| Packaging | 5 mL in 1 BOTTLE (80425-0366-1) |
| FDA SPL set id | 847557 |
| Labeler | Advanced Rx of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2023-11-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 80425-0366 |
NDC Item 00574403105
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-05 |
| NDC Item | 00574403105 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (0574-4031-05) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403110
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-10 |
| NDC Item | 00574403110 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (0574-4031-10) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403125
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-25 |
| NDC Item | 00574403125 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (0574-4031-25) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 24208029505
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-05 |
| NDC Item | 24208029505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029510
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-10 |
| NDC Item | 24208029510 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-10) / 10 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029525
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-25 |
| NDC Item | 24208029525 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-25) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 50090113500
| NDC 9 | 50090-1135 |
|---|---|
| NDC 10 | 50090-1135-0 |
| NDC Item | 50090113500 |
| Packaging | 2.5 mL in 1 BOTTLE (50090-1135-0) |
| FDA SPL set id | 718677 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1135 |
NDC Item 50090113600
| NDC 9 | 50090-1136 |
|---|---|
| NDC 10 | 50090-1136-0 |
| NDC Item | 50090113600 |
| Packaging | 5 mL in 1 BOTTLE (50090-1136-0) |
| FDA SPL set id | 803024 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1136 |
NDC Item 50090189300
| NDC 9 | 50090-1893 |
|---|---|
| NDC 10 | 50090-1893-0 |
| NDC Item | 50090189300 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1893-0) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 771442 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1893 |
NDC Item 50090191400
| NDC 9 | 50090-1914 |
|---|---|
| NDC 10 | 50090-1914-0 |
| NDC Item | 50090191400 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1914-0) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 693387 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1914 |
NDC Item 50090726700
| NDC 9 | 50090-7267 |
|---|---|
| NDC 10 | 50090-7267-0 |
| NDC Item | 50090726700 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (50090-7267-0) |
| ANDA | ANDA212715 |
| FDA SPL set id | 817223 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-7267 |
NDC Item 52959098401
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-01 |
| NDC Item | 52959098401 |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 52959098410
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-10 |
| NDC Item | 52959098410 |
| Packaging | 10 mL in 1 BOTTLE (52959-984-10) |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 55700091505
| NDC 9 | 55700-915 |
|---|---|
| NDC 10 | 55700-915-05 |
| NDC Item | 55700091505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (55700-915-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 653524 |
| Labeler | Quality Care Products, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55700-915 |
NDC Item 61314064705
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-05 |
| NDC Item | 61314064705 |
| Packaging | 5 mL in 1 BOTTLE (61314-647-05) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064710
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-10 |
| NDC Item | 61314064710 |
| Packaging | 10 mL in 1 BOTTLE (61314-647-10) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064725
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-25 |
| NDC Item | 61314064725 |
| Packaging | 2.5 mL in 1 BOTTLE (61314-647-25) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 63629957001
| NDC 9 | 63629-9570 |
|---|---|
| NDC 10 | 63629-9570-1 |
| NDC Item | 63629957001 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (63629-9570-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763323 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9570 |
NDC Item 63629957101
| NDC 9 | 63629-9571 |
|---|---|
| NDC 10 | 63629-9571-1 |
| NDC Item | 63629957101 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (63629-9571-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763569 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9571 |
NDC Item 63629957201
| NDC 9 | 63629-9572 |
|---|---|
| NDC 10 | 63629-9572-1 |
| NDC Item | 63629957201 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (63629-9572-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763269 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9572 |
NDC Item 67296066501
| NDC 9 | 67296-0665 |
|---|---|
| NDC 10 | 67296-0665-1 |
| NDC Item | 67296066501 |
| Packaging | 5 mL in 1 BOTTLE (67296-0665-1) |
| FDA SPL set id | 813479 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 67296-0665 |
NDC Item 68071182102
| NDC 9 | 68071-1821 |
|---|---|
| NDC 10 | 68071-1821-2 |
| NDC Item | 68071182102 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (68071-1821-2) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 858986 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-1821 |
NDC Item 68071420305
| NDC 9 | 68071-4203 |
|---|---|
| NDC 10 | 68071-4203-5 |
| NDC Item | 68071420305 |
| Packaging | 5 mL in 1 BOX (68071-4203-5) |
| ANDA | ANDA064134 |
| FDA SPL set id | 790175 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-4203 |
NDC Item 69238137302
| NDC 9 | 69238-1373 |
|---|---|
| NDC 10 | 69238-1373-2 |
| NDC Item | 69238137302 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1373-2) / 2.5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1373 |
NDC Item 69238137403
| NDC 9 | 69238-1374 |
|---|---|
| NDC 10 | 69238-1374-3 |
| NDC Item | 69238137403 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1374-3) / 5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1374 |
NDC Item 69238137506
| NDC 9 | 69238-1375 |
|---|---|
| NDC 10 | 69238-1375-6 |
| NDC Item | 69238137506 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1375-6) / 10 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1375 |
NDC Item 70518399400
| NDC 9 | 70518-3994 |
|---|---|
| NDC 10 | 70518-3994-0 |
| NDC Item | 70518399400 |
| Packaging | 5 mL in 1 BOTTLE (70518-3994-0) |
| FDA SPL set id | 766955 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2024-01-24 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 70518-3994 |
NDC Item 72162112802
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-2 |
| NDC Item | 72162112802 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (72162-1128-2) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112804
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-4 |
| NDC Item | 72162112804 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (72162-1128-4) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112807
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-7 |
| NDC Item | 72162112807 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (72162-1128-7) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 80425026001
| NDC 9 | 80425-0260 |
|---|---|
| NDC 10 | 80425-0260-1 |
| NDC Item | 80425026001 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (80425-0260-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 848958 |
| Labeler | Advanced Rx Pharmacy of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 80425-0260 |
NDC Item 80425036601
| NDC 9 | 80425-0366 |
|---|---|
| NDC 10 | 80425-0366-1 |
| NDC Item | 80425036601 |
| Packaging | 5 mL in 1 BOTTLE (80425-0366-1) |
| FDA SPL set id | 847557 |
| Labeler | Advanced Rx of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2023-11-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 80425-0366 |
NDC Item 00574403105
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-05 |
| NDC Item | 00574403105 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (0574-4031-05) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403110
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-10 |
| NDC Item | 00574403110 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (0574-4031-10) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403125
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-25 |
| NDC Item | 00574403125 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (0574-4031-25) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 24208029505
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-05 |
| NDC Item | 24208029505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029510
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-10 |
| NDC Item | 24208029510 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-10) / 10 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029525
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-25 |
| NDC Item | 24208029525 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-25) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 50090113500
| NDC 9 | 50090-1135 |
|---|---|
| NDC 10 | 50090-1135-0 |
| NDC Item | 50090113500 |
| Packaging | 2.5 mL in 1 BOTTLE (50090-1135-0) |
| FDA SPL set id | 718677 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1135 |
NDC Item 50090113600
| NDC 9 | 50090-1136 |
|---|---|
| NDC 10 | 50090-1136-0 |
| NDC Item | 50090113600 |
| Packaging | 5 mL in 1 BOTTLE (50090-1136-0) |
| FDA SPL set id | 803024 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1136 |
NDC Item 50090189300
| NDC 9 | 50090-1893 |
|---|---|
| NDC 10 | 50090-1893-0 |
| NDC Item | 50090189300 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1893-0) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 771442 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1893 |
NDC Item 50090191400
| NDC 9 | 50090-1914 |
|---|---|
| NDC 10 | 50090-1914-0 |
| NDC Item | 50090191400 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1914-0) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 693387 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1914 |
NDC Item 50090726700
| NDC 9 | 50090-7267 |
|---|---|
| NDC 10 | 50090-7267-0 |
| NDC Item | 50090726700 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (50090-7267-0) |
| ANDA | ANDA212715 |
| FDA SPL set id | 817223 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-7267 |
NDC Item 52959098401
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-01 |
| NDC Item | 52959098401 |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 52959098410
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-10 |
| NDC Item | 52959098410 |
| Packaging | 10 mL in 1 BOTTLE (52959-984-10) |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 55700091505
| NDC 9 | 55700-915 |
|---|---|
| NDC 10 | 55700-915-05 |
| NDC Item | 55700091505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (55700-915-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 653524 |
| Labeler | Quality Care Products, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55700-915 |
NDC Item 61314064705
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-05 |
| NDC Item | 61314064705 |
| Packaging | 5 mL in 1 BOTTLE (61314-647-05) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064710
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-10 |
| NDC Item | 61314064710 |
| Packaging | 10 mL in 1 BOTTLE (61314-647-10) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064725
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-25 |
| NDC Item | 61314064725 |
| Packaging | 2.5 mL in 1 BOTTLE (61314-647-25) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 63629957001
| NDC 9 | 63629-9570 |
|---|---|
| NDC 10 | 63629-9570-1 |
| NDC Item | 63629957001 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (63629-9570-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763323 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9570 |
NDC Item 63629957101
| NDC 9 | 63629-9571 |
|---|---|
| NDC 10 | 63629-9571-1 |
| NDC Item | 63629957101 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (63629-9571-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763569 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9571 |
NDC Item 63629957201
| NDC 9 | 63629-9572 |
|---|---|
| NDC 10 | 63629-9572-1 |
| NDC Item | 63629957201 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (63629-9572-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763269 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9572 |
NDC Item 67296066501
| NDC 9 | 67296-0665 |
|---|---|
| NDC 10 | 67296-0665-1 |
| NDC Item | 67296066501 |
| Packaging | 5 mL in 1 BOTTLE (67296-0665-1) |
| FDA SPL set id | 813479 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 67296-0665 |
NDC Item 68071182102
| NDC 9 | 68071-1821 |
|---|---|
| NDC 10 | 68071-1821-2 |
| NDC Item | 68071182102 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (68071-1821-2) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 858986 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-1821 |
NDC Item 68071420305
| NDC 9 | 68071-4203 |
|---|---|
| NDC 10 | 68071-4203-5 |
| NDC Item | 68071420305 |
| Packaging | 5 mL in 1 BOX (68071-4203-5) |
| ANDA | ANDA064134 |
| FDA SPL set id | 790175 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-4203 |
NDC Item 69238137302
| NDC 9 | 69238-1373 |
|---|---|
| NDC 10 | 69238-1373-2 |
| NDC Item | 69238137302 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1373-2) / 2.5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1373 |
NDC Item 69238137403
| NDC 9 | 69238-1374 |
|---|---|
| NDC 10 | 69238-1374-3 |
| NDC Item | 69238137403 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1374-3) / 5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1374 |
NDC Item 69238137506
| NDC 9 | 69238-1375 |
|---|---|
| NDC 10 | 69238-1375-6 |
| NDC Item | 69238137506 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1375-6) / 10 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1375 |
NDC Item 70518399400
| NDC 9 | 70518-3994 |
|---|---|
| NDC 10 | 70518-3994-0 |
| NDC Item | 70518399400 |
| Packaging | 5 mL in 1 BOTTLE (70518-3994-0) |
| FDA SPL set id | 766955 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2024-01-24 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 70518-3994 |
NDC Item 72162112802
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-2 |
| NDC Item | 72162112802 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (72162-1128-2) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112804
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-4 |
| NDC Item | 72162112804 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (72162-1128-4) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112807
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-7 |
| NDC Item | 72162112807 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (72162-1128-7) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 80425026001
| NDC 9 | 80425-0260 |
|---|---|
| NDC 10 | 80425-0260-1 |
| NDC Item | 80425026001 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (80425-0260-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 848958 |
| Labeler | Advanced Rx Pharmacy of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 80425-0260 |
NDC Item 80425036601
| NDC 9 | 80425-0366 |
|---|---|
| NDC 10 | 80425-0366-1 |
| NDC Item | 80425036601 |
| Packaging | 5 mL in 1 BOTTLE (80425-0366-1) |
| FDA SPL set id | 847557 |
| Labeler | Advanced Rx of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2023-11-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 80425-0366 |
NDC Item 00574403105
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-05 |
| NDC Item | 00574403105 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (0574-4031-05) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403110
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-10 |
| NDC Item | 00574403110 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (0574-4031-10) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403125
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-25 |
| NDC Item | 00574403125 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (0574-4031-25) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 24208029505
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-05 |
| NDC Item | 24208029505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029510
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-10 |
| NDC Item | 24208029510 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-10) / 10 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029525
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-25 |
| NDC Item | 24208029525 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-25) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 50090113500
| NDC 9 | 50090-1135 |
|---|---|
| NDC 10 | 50090-1135-0 |
| NDC Item | 50090113500 |
| Packaging | 2.5 mL in 1 BOTTLE (50090-1135-0) |
| FDA SPL set id | 718677 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1135 |
NDC Item 50090113600
| NDC 9 | 50090-1136 |
|---|---|
| NDC 10 | 50090-1136-0 |
| NDC Item | 50090113600 |
| Packaging | 5 mL in 1 BOTTLE (50090-1136-0) |
| FDA SPL set id | 803024 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1136 |
NDC Item 50090189300
| NDC 9 | 50090-1893 |
|---|---|
| NDC 10 | 50090-1893-0 |
| NDC Item | 50090189300 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1893-0) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 771442 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1893 |
NDC Item 50090191400
| NDC 9 | 50090-1914 |
|---|---|
| NDC 10 | 50090-1914-0 |
| NDC Item | 50090191400 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1914-0) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 693387 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1914 |
NDC Item 50090726700
| NDC 9 | 50090-7267 |
|---|---|
| NDC 10 | 50090-7267-0 |
| NDC Item | 50090726700 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (50090-7267-0) |
| ANDA | ANDA212715 |
| FDA SPL set id | 817223 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-7267 |
NDC Item 52959098401
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-01 |
| NDC Item | 52959098401 |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 52959098410
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-10 |
| NDC Item | 52959098410 |
| Packaging | 10 mL in 1 BOTTLE (52959-984-10) |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 55700091505
| NDC 9 | 55700-915 |
|---|---|
| NDC 10 | 55700-915-05 |
| NDC Item | 55700091505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (55700-915-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 653524 |
| Labeler | Quality Care Products, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55700-915 |
NDC Item 61314064705
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-05 |
| NDC Item | 61314064705 |
| Packaging | 5 mL in 1 BOTTLE (61314-647-05) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064710
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-10 |
| NDC Item | 61314064710 |
| Packaging | 10 mL in 1 BOTTLE (61314-647-10) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064725
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-25 |
| NDC Item | 61314064725 |
| Packaging | 2.5 mL in 1 BOTTLE (61314-647-25) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 63629957001
| NDC 9 | 63629-9570 |
|---|---|
| NDC 10 | 63629-9570-1 |
| NDC Item | 63629957001 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (63629-9570-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763323 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9570 |
NDC Item 63629957101
| NDC 9 | 63629-9571 |
|---|---|
| NDC 10 | 63629-9571-1 |
| NDC Item | 63629957101 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (63629-9571-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763569 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9571 |
NDC Item 63629957201
| NDC 9 | 63629-9572 |
|---|---|
| NDC 10 | 63629-9572-1 |
| NDC Item | 63629957201 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (63629-9572-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763269 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9572 |
NDC Item 67296066501
| NDC 9 | 67296-0665 |
|---|---|
| NDC 10 | 67296-0665-1 |
| NDC Item | 67296066501 |
| Packaging | 5 mL in 1 BOTTLE (67296-0665-1) |
| FDA SPL set id | 813479 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 67296-0665 |
NDC Item 68071182102
| NDC 9 | 68071-1821 |
|---|---|
| NDC 10 | 68071-1821-2 |
| NDC Item | 68071182102 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (68071-1821-2) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 858986 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-1821 |
NDC Item 68071420305
| NDC 9 | 68071-4203 |
|---|---|
| NDC 10 | 68071-4203-5 |
| NDC Item | 68071420305 |
| Packaging | 5 mL in 1 BOX (68071-4203-5) |
| ANDA | ANDA064134 |
| FDA SPL set id | 790175 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-4203 |
NDC Item 69238137302
| NDC 9 | 69238-1373 |
|---|---|
| NDC 10 | 69238-1373-2 |
| NDC Item | 69238137302 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1373-2) / 2.5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1373 |
NDC Item 69238137403
| NDC 9 | 69238-1374 |
|---|---|
| NDC 10 | 69238-1374-3 |
| NDC Item | 69238137403 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1374-3) / 5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1374 |
NDC Item 69238137506
| NDC 9 | 69238-1375 |
|---|---|
| NDC 10 | 69238-1375-6 |
| NDC Item | 69238137506 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1375-6) / 10 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1375 |
NDC Item 70518399400
| NDC 9 | 70518-3994 |
|---|---|
| NDC 10 | 70518-3994-0 |
| NDC Item | 70518399400 |
| Packaging | 5 mL in 1 BOTTLE (70518-3994-0) |
| FDA SPL set id | 766955 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2024-01-24 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 70518-3994 |
NDC Item 72162112802
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-2 |
| NDC Item | 72162112802 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (72162-1128-2) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112804
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-4 |
| NDC Item | 72162112804 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (72162-1128-4) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112807
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-7 |
| NDC Item | 72162112807 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (72162-1128-7) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 80425026001
| NDC 9 | 80425-0260 |
|---|---|
| NDC 10 | 80425-0260-1 |
| NDC Item | 80425026001 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (80425-0260-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 848958 |
| Labeler | Advanced Rx Pharmacy of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 80425-0260 |
NDC Item 80425036601
| NDC 9 | 80425-0366 |
|---|---|
| NDC 10 | 80425-0366-1 |
| NDC Item | 80425036601 |
| Packaging | 5 mL in 1 BOTTLE (80425-0366-1) |
| FDA SPL set id | 847557 |
| Labeler | Advanced Rx of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2023-11-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 80425-0366 |
NDC Item 00574403105
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-05 |
| NDC Item | 00574403105 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (0574-4031-05) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403110
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-10 |
| NDC Item | 00574403110 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (0574-4031-10) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403125
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-25 |
| NDC Item | 00574403125 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (0574-4031-25) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 24208029505
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-05 |
| NDC Item | 24208029505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029510
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-10 |
| NDC Item | 24208029510 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-10) / 10 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029525
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-25 |
| NDC Item | 24208029525 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-25) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 50090113500
| NDC 9 | 50090-1135 |
|---|---|
| NDC 10 | 50090-1135-0 |
| NDC Item | 50090113500 |
| Packaging | 2.5 mL in 1 BOTTLE (50090-1135-0) |
| FDA SPL set id | 718677 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1135 |
NDC Item 50090113600
| NDC 9 | 50090-1136 |
|---|---|
| NDC 10 | 50090-1136-0 |
| NDC Item | 50090113600 |
| Packaging | 5 mL in 1 BOTTLE (50090-1136-0) |
| FDA SPL set id | 803024 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1136 |
NDC Item 50090189300
| NDC 9 | 50090-1893 |
|---|---|
| NDC 10 | 50090-1893-0 |
| NDC Item | 50090189300 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1893-0) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 771442 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1893 |
NDC Item 50090191400
| NDC 9 | 50090-1914 |
|---|---|
| NDC 10 | 50090-1914-0 |
| NDC Item | 50090191400 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1914-0) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 693387 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1914 |
NDC Item 50090726700
| NDC 9 | 50090-7267 |
|---|---|
| NDC 10 | 50090-7267-0 |
| NDC Item | 50090726700 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (50090-7267-0) |
| ANDA | ANDA212715 |
| FDA SPL set id | 817223 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-7267 |
NDC Item 52959098401
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-01 |
| NDC Item | 52959098401 |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 52959098410
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-10 |
| NDC Item | 52959098410 |
| Packaging | 10 mL in 1 BOTTLE (52959-984-10) |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 55700091505
| NDC 9 | 55700-915 |
|---|---|
| NDC 10 | 55700-915-05 |
| NDC Item | 55700091505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (55700-915-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 653524 |
| Labeler | Quality Care Products, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55700-915 |
NDC Item 61314064705
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-05 |
| NDC Item | 61314064705 |
| Packaging | 5 mL in 1 BOTTLE (61314-647-05) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064710
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-10 |
| NDC Item | 61314064710 |
| Packaging | 10 mL in 1 BOTTLE (61314-647-10) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064725
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-25 |
| NDC Item | 61314064725 |
| Packaging | 2.5 mL in 1 BOTTLE (61314-647-25) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 63629957001
| NDC 9 | 63629-9570 |
|---|---|
| NDC 10 | 63629-9570-1 |
| NDC Item | 63629957001 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (63629-9570-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763323 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9570 |
NDC Item 63629957101
| NDC 9 | 63629-9571 |
|---|---|
| NDC 10 | 63629-9571-1 |
| NDC Item | 63629957101 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (63629-9571-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763569 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9571 |
NDC Item 63629957201
| NDC 9 | 63629-9572 |
|---|---|
| NDC 10 | 63629-9572-1 |
| NDC Item | 63629957201 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (63629-9572-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763269 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9572 |
NDC Item 67296066501
| NDC 9 | 67296-0665 |
|---|---|
| NDC 10 | 67296-0665-1 |
| NDC Item | 67296066501 |
| Packaging | 5 mL in 1 BOTTLE (67296-0665-1) |
| FDA SPL set id | 813479 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 67296-0665 |
NDC Item 68071182102
| NDC 9 | 68071-1821 |
|---|---|
| NDC 10 | 68071-1821-2 |
| NDC Item | 68071182102 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (68071-1821-2) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 858986 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-1821 |
NDC Item 68071420305
| NDC 9 | 68071-4203 |
|---|---|
| NDC 10 | 68071-4203-5 |
| NDC Item | 68071420305 |
| Packaging | 5 mL in 1 BOX (68071-4203-5) |
| ANDA | ANDA064134 |
| FDA SPL set id | 790175 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-4203 |
NDC Item 69238137302
| NDC 9 | 69238-1373 |
|---|---|
| NDC 10 | 69238-1373-2 |
| NDC Item | 69238137302 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1373-2) / 2.5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1373 |
NDC Item 69238137403
| NDC 9 | 69238-1374 |
|---|---|
| NDC 10 | 69238-1374-3 |
| NDC Item | 69238137403 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1374-3) / 5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1374 |
NDC Item 69238137506
| NDC 9 | 69238-1375 |
|---|---|
| NDC 10 | 69238-1375-6 |
| NDC Item | 69238137506 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1375-6) / 10 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1375 |
NDC Item 70518399400
| NDC 9 | 70518-3994 |
|---|---|
| NDC 10 | 70518-3994-0 |
| NDC Item | 70518399400 |
| Packaging | 5 mL in 1 BOTTLE (70518-3994-0) |
| FDA SPL set id | 766955 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2024-01-24 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 70518-3994 |
NDC Item 72162112802
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-2 |
| NDC Item | 72162112802 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (72162-1128-2) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112804
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-4 |
| NDC Item | 72162112804 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (72162-1128-4) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112807
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-7 |
| NDC Item | 72162112807 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (72162-1128-7) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 80425026001
| NDC 9 | 80425-0260 |
|---|---|
| NDC 10 | 80425-0260-1 |
| NDC Item | 80425026001 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (80425-0260-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 848958 |
| Labeler | Advanced Rx Pharmacy of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 80425-0260 |
NDC Item 80425036601
| NDC 9 | 80425-0366 |
|---|---|
| NDC 10 | 80425-0366-1 |
| NDC Item | 80425036601 |
| Packaging | 5 mL in 1 BOTTLE (80425-0366-1) |
| FDA SPL set id | 847557 |
| Labeler | Advanced Rx of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2023-11-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 80425-0366 |
NDC Item 00574403105
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-05 |
| NDC Item | 00574403105 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (0574-4031-05) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403110
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-10 |
| NDC Item | 00574403110 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (0574-4031-10) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403125
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-25 |
| NDC Item | 00574403125 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (0574-4031-25) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 24208029505
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-05 |
| NDC Item | 24208029505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029510
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-10 |
| NDC Item | 24208029510 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-10) / 10 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029525
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-25 |
| NDC Item | 24208029525 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-25) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 50090113500
| NDC 9 | 50090-1135 |
|---|---|
| NDC 10 | 50090-1135-0 |
| NDC Item | 50090113500 |
| Packaging | 2.5 mL in 1 BOTTLE (50090-1135-0) |
| FDA SPL set id | 718677 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1135 |
NDC Item 50090113600
| NDC 9 | 50090-1136 |
|---|---|
| NDC 10 | 50090-1136-0 |
| NDC Item | 50090113600 |
| Packaging | 5 mL in 1 BOTTLE (50090-1136-0) |
| FDA SPL set id | 803024 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1136 |
NDC Item 50090189300
| NDC 9 | 50090-1893 |
|---|---|
| NDC 10 | 50090-1893-0 |
| NDC Item | 50090189300 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1893-0) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 771442 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1893 |
NDC Item 50090191400
| NDC 9 | 50090-1914 |
|---|---|
| NDC 10 | 50090-1914-0 |
| NDC Item | 50090191400 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1914-0) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 693387 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1914 |
NDC Item 50090726700
| NDC 9 | 50090-7267 |
|---|---|
| NDC 10 | 50090-7267-0 |
| NDC Item | 50090726700 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (50090-7267-0) |
| ANDA | ANDA212715 |
| FDA SPL set id | 817223 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-7267 |
NDC Item 52959098401
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-01 |
| NDC Item | 52959098401 |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 52959098410
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-10 |
| NDC Item | 52959098410 |
| Packaging | 10 mL in 1 BOTTLE (52959-984-10) |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 55700091505
| NDC 9 | 55700-915 |
|---|---|
| NDC 10 | 55700-915-05 |
| NDC Item | 55700091505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (55700-915-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 653524 |
| Labeler | Quality Care Products, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55700-915 |
NDC Item 61314064705
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-05 |
| NDC Item | 61314064705 |
| Packaging | 5 mL in 1 BOTTLE (61314-647-05) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064710
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-10 |
| NDC Item | 61314064710 |
| Packaging | 10 mL in 1 BOTTLE (61314-647-10) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064725
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-25 |
| NDC Item | 61314064725 |
| Packaging | 2.5 mL in 1 BOTTLE (61314-647-25) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 63629957001
| NDC 9 | 63629-9570 |
|---|---|
| NDC 10 | 63629-9570-1 |
| NDC Item | 63629957001 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (63629-9570-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763323 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9570 |
NDC Item 63629957101
| NDC 9 | 63629-9571 |
|---|---|
| NDC 10 | 63629-9571-1 |
| NDC Item | 63629957101 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (63629-9571-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763569 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9571 |
NDC Item 63629957201
| NDC 9 | 63629-9572 |
|---|---|
| NDC 10 | 63629-9572-1 |
| NDC Item | 63629957201 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (63629-9572-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763269 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9572 |
NDC Item 67296066501
| NDC 9 | 67296-0665 |
|---|---|
| NDC 10 | 67296-0665-1 |
| NDC Item | 67296066501 |
| Packaging | 5 mL in 1 BOTTLE (67296-0665-1) |
| FDA SPL set id | 813479 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 67296-0665 |
NDC Item 68071182102
| NDC 9 | 68071-1821 |
|---|---|
| NDC 10 | 68071-1821-2 |
| NDC Item | 68071182102 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (68071-1821-2) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 858986 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-1821 |
NDC Item 68071420305
| NDC 9 | 68071-4203 |
|---|---|
| NDC 10 | 68071-4203-5 |
| NDC Item | 68071420305 |
| Packaging | 5 mL in 1 BOX (68071-4203-5) |
| ANDA | ANDA064134 |
| FDA SPL set id | 790175 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-4203 |
NDC Item 69238137302
| NDC 9 | 69238-1373 |
|---|---|
| NDC 10 | 69238-1373-2 |
| NDC Item | 69238137302 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1373-2) / 2.5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1373 |
NDC Item 69238137403
| NDC 9 | 69238-1374 |
|---|---|
| NDC 10 | 69238-1374-3 |
| NDC Item | 69238137403 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1374-3) / 5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1374 |
NDC Item 69238137506
| NDC 9 | 69238-1375 |
|---|---|
| NDC 10 | 69238-1375-6 |
| NDC Item | 69238137506 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1375-6) / 10 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1375 |
NDC Item 70518399400
| NDC 9 | 70518-3994 |
|---|---|
| NDC 10 | 70518-3994-0 |
| NDC Item | 70518399400 |
| Packaging | 5 mL in 1 BOTTLE (70518-3994-0) |
| FDA SPL set id | 766955 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2024-01-24 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 70518-3994 |
NDC Item 72162112802
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-2 |
| NDC Item | 72162112802 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (72162-1128-2) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112804
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-4 |
| NDC Item | 72162112804 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (72162-1128-4) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112807
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-7 |
| NDC Item | 72162112807 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (72162-1128-7) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 80425026001
| NDC 9 | 80425-0260 |
|---|---|
| NDC 10 | 80425-0260-1 |
| NDC Item | 80425026001 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (80425-0260-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 848958 |
| Labeler | Advanced Rx Pharmacy of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 80425-0260 |
NDC Item 80425036601
| NDC 9 | 80425-0366 |
|---|---|
| NDC 10 | 80425-0366-1 |
| NDC Item | 80425036601 |
| Packaging | 5 mL in 1 BOTTLE (80425-0366-1) |
| FDA SPL set id | 847557 |
| Labeler | Advanced Rx of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2023-11-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 80425-0366 |
NDC Item 00574403105
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-05 |
| NDC Item | 00574403105 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (0574-4031-05) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403110
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-10 |
| NDC Item | 00574403110 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (0574-4031-10) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403125
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-25 |
| NDC Item | 00574403125 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (0574-4031-25) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 24208029505
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-05 |
| NDC Item | 24208029505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029510
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-10 |
| NDC Item | 24208029510 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-10) / 10 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029525
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-25 |
| NDC Item | 24208029525 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-25) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 50090113500
| NDC 9 | 50090-1135 |
|---|---|
| NDC 10 | 50090-1135-0 |
| NDC Item | 50090113500 |
| Packaging | 2.5 mL in 1 BOTTLE (50090-1135-0) |
| FDA SPL set id | 718677 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1135 |
NDC Item 50090113600
| NDC 9 | 50090-1136 |
|---|---|
| NDC 10 | 50090-1136-0 |
| NDC Item | 50090113600 |
| Packaging | 5 mL in 1 BOTTLE (50090-1136-0) |
| FDA SPL set id | 803024 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1136 |
NDC Item 50090189300
| NDC 9 | 50090-1893 |
|---|---|
| NDC 10 | 50090-1893-0 |
| NDC Item | 50090189300 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1893-0) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 771442 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1893 |
NDC Item 50090191400
| NDC 9 | 50090-1914 |
|---|---|
| NDC 10 | 50090-1914-0 |
| NDC Item | 50090191400 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1914-0) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 693387 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1914 |
NDC Item 50090726700
| NDC 9 | 50090-7267 |
|---|---|
| NDC 10 | 50090-7267-0 |
| NDC Item | 50090726700 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (50090-7267-0) |
| ANDA | ANDA212715 |
| FDA SPL set id | 817223 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-7267 |
NDC Item 52959098401
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-01 |
| NDC Item | 52959098401 |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 52959098410
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-10 |
| NDC Item | 52959098410 |
| Packaging | 10 mL in 1 BOTTLE (52959-984-10) |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 55700091505
| NDC 9 | 55700-915 |
|---|---|
| NDC 10 | 55700-915-05 |
| NDC Item | 55700091505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (55700-915-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 653524 |
| Labeler | Quality Care Products, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55700-915 |
NDC Item 61314064705
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-05 |
| NDC Item | 61314064705 |
| Packaging | 5 mL in 1 BOTTLE (61314-647-05) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064710
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-10 |
| NDC Item | 61314064710 |
| Packaging | 10 mL in 1 BOTTLE (61314-647-10) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064725
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-25 |
| NDC Item | 61314064725 |
| Packaging | 2.5 mL in 1 BOTTLE (61314-647-25) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 63629957001
| NDC 9 | 63629-9570 |
|---|---|
| NDC 10 | 63629-9570-1 |
| NDC Item | 63629957001 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (63629-9570-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763323 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9570 |
NDC Item 63629957101
| NDC 9 | 63629-9571 |
|---|---|
| NDC 10 | 63629-9571-1 |
| NDC Item | 63629957101 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (63629-9571-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763569 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9571 |
NDC Item 63629957201
| NDC 9 | 63629-9572 |
|---|---|
| NDC 10 | 63629-9572-1 |
| NDC Item | 63629957201 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (63629-9572-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763269 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9572 |
NDC Item 67296066501
| NDC 9 | 67296-0665 |
|---|---|
| NDC 10 | 67296-0665-1 |
| NDC Item | 67296066501 |
| Packaging | 5 mL in 1 BOTTLE (67296-0665-1) |
| FDA SPL set id | 813479 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 67296-0665 |
NDC Item 68071182102
| NDC 9 | 68071-1821 |
|---|---|
| NDC 10 | 68071-1821-2 |
| NDC Item | 68071182102 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (68071-1821-2) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 858986 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-1821 |
NDC Item 68071420305
| NDC 9 | 68071-4203 |
|---|---|
| NDC 10 | 68071-4203-5 |
| NDC Item | 68071420305 |
| Packaging | 5 mL in 1 BOX (68071-4203-5) |
| ANDA | ANDA064134 |
| FDA SPL set id | 790175 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-4203 |
NDC Item 69238137302
| NDC 9 | 69238-1373 |
|---|---|
| NDC 10 | 69238-1373-2 |
| NDC Item | 69238137302 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1373-2) / 2.5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1373 |
NDC Item 69238137403
| NDC 9 | 69238-1374 |
|---|---|
| NDC 10 | 69238-1374-3 |
| NDC Item | 69238137403 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1374-3) / 5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1374 |
NDC Item 69238137506
| NDC 9 | 69238-1375 |
|---|---|
| NDC 10 | 69238-1375-6 |
| NDC Item | 69238137506 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1375-6) / 10 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1375 |
NDC Item 70518399400
| NDC 9 | 70518-3994 |
|---|---|
| NDC 10 | 70518-3994-0 |
| NDC Item | 70518399400 |
| Packaging | 5 mL in 1 BOTTLE (70518-3994-0) |
| FDA SPL set id | 766955 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2024-01-24 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 70518-3994 |
NDC Item 72162112802
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-2 |
| NDC Item | 72162112802 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (72162-1128-2) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112804
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-4 |
| NDC Item | 72162112804 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (72162-1128-4) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112807
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-7 |
| NDC Item | 72162112807 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (72162-1128-7) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 80425026001
| NDC 9 | 80425-0260 |
|---|---|
| NDC 10 | 80425-0260-1 |
| NDC Item | 80425026001 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (80425-0260-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 848958 |
| Labeler | Advanced Rx Pharmacy of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 80425-0260 |
NDC Item 80425036601
| NDC 9 | 80425-0366 |
|---|---|
| NDC 10 | 80425-0366-1 |
| NDC Item | 80425036601 |
| Packaging | 5 mL in 1 BOTTLE (80425-0366-1) |
| FDA SPL set id | 847557 |
| Labeler | Advanced Rx of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2023-11-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 80425-0366 |
NDC Item 00574403105
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-05 |
| NDC Item | 00574403105 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (0574-4031-05) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403110
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-10 |
| NDC Item | 00574403110 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (0574-4031-10) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403125
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-25 |
| NDC Item | 00574403125 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (0574-4031-25) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 24208029505
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-05 |
| NDC Item | 24208029505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029510
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-10 |
| NDC Item | 24208029510 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-10) / 10 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029525
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-25 |
| NDC Item | 24208029525 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-25) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 50090113500
| NDC 9 | 50090-1135 |
|---|---|
| NDC 10 | 50090-1135-0 |
| NDC Item | 50090113500 |
| Packaging | 2.5 mL in 1 BOTTLE (50090-1135-0) |
| FDA SPL set id | 718677 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1135 |
NDC Item 50090113600
| NDC 9 | 50090-1136 |
|---|---|
| NDC 10 | 50090-1136-0 |
| NDC Item | 50090113600 |
| Packaging | 5 mL in 1 BOTTLE (50090-1136-0) |
| FDA SPL set id | 803024 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1136 |
NDC Item 50090189300
| NDC 9 | 50090-1893 |
|---|---|
| NDC 10 | 50090-1893-0 |
| NDC Item | 50090189300 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1893-0) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 771442 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1893 |
NDC Item 50090191400
| NDC 9 | 50090-1914 |
|---|---|
| NDC 10 | 50090-1914-0 |
| NDC Item | 50090191400 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1914-0) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 693387 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1914 |
NDC Item 50090726700
| NDC 9 | 50090-7267 |
|---|---|
| NDC 10 | 50090-7267-0 |
| NDC Item | 50090726700 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (50090-7267-0) |
| ANDA | ANDA212715 |
| FDA SPL set id | 817223 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-7267 |
NDC Item 52959098401
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-01 |
| NDC Item | 52959098401 |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 52959098410
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-10 |
| NDC Item | 52959098410 |
| Packaging | 10 mL in 1 BOTTLE (52959-984-10) |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 55700091505
| NDC 9 | 55700-915 |
|---|---|
| NDC 10 | 55700-915-05 |
| NDC Item | 55700091505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (55700-915-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 653524 |
| Labeler | Quality Care Products, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55700-915 |
NDC Item 61314064705
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-05 |
| NDC Item | 61314064705 |
| Packaging | 5 mL in 1 BOTTLE (61314-647-05) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064710
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-10 |
| NDC Item | 61314064710 |
| Packaging | 10 mL in 1 BOTTLE (61314-647-10) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064725
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-25 |
| NDC Item | 61314064725 |
| Packaging | 2.5 mL in 1 BOTTLE (61314-647-25) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 63629957001
| NDC 9 | 63629-9570 |
|---|---|
| NDC 10 | 63629-9570-1 |
| NDC Item | 63629957001 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (63629-9570-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763323 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9570 |
NDC Item 63629957101
| NDC 9 | 63629-9571 |
|---|---|
| NDC 10 | 63629-9571-1 |
| NDC Item | 63629957101 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (63629-9571-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763569 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9571 |
NDC Item 63629957201
| NDC 9 | 63629-9572 |
|---|---|
| NDC 10 | 63629-9572-1 |
| NDC Item | 63629957201 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (63629-9572-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763269 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9572 |
NDC Item 67296066501
| NDC 9 | 67296-0665 |
|---|---|
| NDC 10 | 67296-0665-1 |
| NDC Item | 67296066501 |
| Packaging | 5 mL in 1 BOTTLE (67296-0665-1) |
| FDA SPL set id | 813479 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 67296-0665 |
NDC Item 68071182102
| NDC 9 | 68071-1821 |
|---|---|
| NDC 10 | 68071-1821-2 |
| NDC Item | 68071182102 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (68071-1821-2) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 858986 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-1821 |
NDC Item 68071420305
| NDC 9 | 68071-4203 |
|---|---|
| NDC 10 | 68071-4203-5 |
| NDC Item | 68071420305 |
| Packaging | 5 mL in 1 BOX (68071-4203-5) |
| ANDA | ANDA064134 |
| FDA SPL set id | 790175 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-4203 |
NDC Item 69238137302
| NDC 9 | 69238-1373 |
|---|---|
| NDC 10 | 69238-1373-2 |
| NDC Item | 69238137302 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1373-2) / 2.5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1373 |
NDC Item 69238137403
| NDC 9 | 69238-1374 |
|---|---|
| NDC 10 | 69238-1374-3 |
| NDC Item | 69238137403 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1374-3) / 5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1374 |
NDC Item 69238137506
| NDC 9 | 69238-1375 |
|---|---|
| NDC 10 | 69238-1375-6 |
| NDC Item | 69238137506 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1375-6) / 10 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1375 |
NDC Item 70518399400
| NDC 9 | 70518-3994 |
|---|---|
| NDC 10 | 70518-3994-0 |
| NDC Item | 70518399400 |
| Packaging | 5 mL in 1 BOTTLE (70518-3994-0) |
| FDA SPL set id | 766955 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2024-01-24 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 70518-3994 |
NDC Item 72162112802
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-2 |
| NDC Item | 72162112802 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (72162-1128-2) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112804
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-4 |
| NDC Item | 72162112804 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (72162-1128-4) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112807
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-7 |
| NDC Item | 72162112807 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (72162-1128-7) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 80425026001
| NDC 9 | 80425-0260 |
|---|---|
| NDC 10 | 80425-0260-1 |
| NDC Item | 80425026001 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (80425-0260-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 848958 |
| Labeler | Advanced Rx Pharmacy of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 80425-0260 |
NDC Item 80425036601
| NDC 9 | 80425-0366 |
|---|---|
| NDC 10 | 80425-0366-1 |
| NDC Item | 80425036601 |
| Packaging | 5 mL in 1 BOTTLE (80425-0366-1) |
| FDA SPL set id | 847557 |
| Labeler | Advanced Rx of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2023-11-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 80425-0366 |
NDC Item 00574403105
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-05 |
| NDC Item | 00574403105 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (0574-4031-05) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403110
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-10 |
| NDC Item | 00574403110 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (0574-4031-10) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403125
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-25 |
| NDC Item | 00574403125 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (0574-4031-25) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 24208029505
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-05 |
| NDC Item | 24208029505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029510
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-10 |
| NDC Item | 24208029510 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-10) / 10 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029525
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-25 |
| NDC Item | 24208029525 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-25) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 50090113500
| NDC 9 | 50090-1135 |
|---|---|
| NDC 10 | 50090-1135-0 |
| NDC Item | 50090113500 |
| Packaging | 2.5 mL in 1 BOTTLE (50090-1135-0) |
| FDA SPL set id | 718677 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1135 |
NDC Item 50090113600
| NDC 9 | 50090-1136 |
|---|---|
| NDC 10 | 50090-1136-0 |
| NDC Item | 50090113600 |
| Packaging | 5 mL in 1 BOTTLE (50090-1136-0) |
| FDA SPL set id | 803024 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1136 |
NDC Item 50090189300
| NDC 9 | 50090-1893 |
|---|---|
| NDC 10 | 50090-1893-0 |
| NDC Item | 50090189300 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1893-0) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 771442 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1893 |
NDC Item 50090191400
| NDC 9 | 50090-1914 |
|---|---|
| NDC 10 | 50090-1914-0 |
| NDC Item | 50090191400 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1914-0) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 693387 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1914 |
NDC Item 50090726700
| NDC 9 | 50090-7267 |
|---|---|
| NDC 10 | 50090-7267-0 |
| NDC Item | 50090726700 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (50090-7267-0) |
| ANDA | ANDA212715 |
| FDA SPL set id | 817223 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-7267 |
NDC Item 52959098401
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-01 |
| NDC Item | 52959098401 |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 52959098410
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-10 |
| NDC Item | 52959098410 |
| Packaging | 10 mL in 1 BOTTLE (52959-984-10) |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 55700091505
| NDC 9 | 55700-915 |
|---|---|
| NDC 10 | 55700-915-05 |
| NDC Item | 55700091505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (55700-915-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 653524 |
| Labeler | Quality Care Products, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55700-915 |
NDC Item 61314064705
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-05 |
| NDC Item | 61314064705 |
| Packaging | 5 mL in 1 BOTTLE (61314-647-05) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064710
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-10 |
| NDC Item | 61314064710 |
| Packaging | 10 mL in 1 BOTTLE (61314-647-10) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064725
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-25 |
| NDC Item | 61314064725 |
| Packaging | 2.5 mL in 1 BOTTLE (61314-647-25) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 63629957001
| NDC 9 | 63629-9570 |
|---|---|
| NDC 10 | 63629-9570-1 |
| NDC Item | 63629957001 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (63629-9570-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763323 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9570 |
NDC Item 63629957101
| NDC 9 | 63629-9571 |
|---|---|
| NDC 10 | 63629-9571-1 |
| NDC Item | 63629957101 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (63629-9571-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763569 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9571 |
NDC Item 63629957201
| NDC 9 | 63629-9572 |
|---|---|
| NDC 10 | 63629-9572-1 |
| NDC Item | 63629957201 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (63629-9572-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763269 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9572 |
NDC Item 67296066501
| NDC 9 | 67296-0665 |
|---|---|
| NDC 10 | 67296-0665-1 |
| NDC Item | 67296066501 |
| Packaging | 5 mL in 1 BOTTLE (67296-0665-1) |
| FDA SPL set id | 813479 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 67296-0665 |
NDC Item 68071182102
| NDC 9 | 68071-1821 |
|---|---|
| NDC 10 | 68071-1821-2 |
| NDC Item | 68071182102 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (68071-1821-2) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 858986 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-1821 |
NDC Item 68071420305
| NDC 9 | 68071-4203 |
|---|---|
| NDC 10 | 68071-4203-5 |
| NDC Item | 68071420305 |
| Packaging | 5 mL in 1 BOX (68071-4203-5) |
| ANDA | ANDA064134 |
| FDA SPL set id | 790175 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-4203 |
NDC Item 69238137302
| NDC 9 | 69238-1373 |
|---|---|
| NDC 10 | 69238-1373-2 |
| NDC Item | 69238137302 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1373-2) / 2.5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1373 |
NDC Item 69238137403
| NDC 9 | 69238-1374 |
|---|---|
| NDC 10 | 69238-1374-3 |
| NDC Item | 69238137403 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1374-3) / 5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1374 |
NDC Item 69238137506
| NDC 9 | 69238-1375 |
|---|---|
| NDC 10 | 69238-1375-6 |
| NDC Item | 69238137506 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1375-6) / 10 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1375 |
NDC Item 70518399400
| NDC 9 | 70518-3994 |
|---|---|
| NDC 10 | 70518-3994-0 |
| NDC Item | 70518399400 |
| Packaging | 5 mL in 1 BOTTLE (70518-3994-0) |
| FDA SPL set id | 766955 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2024-01-24 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 70518-3994 |
NDC Item 72162112802
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-2 |
| NDC Item | 72162112802 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (72162-1128-2) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112804
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-4 |
| NDC Item | 72162112804 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (72162-1128-4) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112807
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-7 |
| NDC Item | 72162112807 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (72162-1128-7) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 80425026001
| NDC 9 | 80425-0260 |
|---|---|
| NDC 10 | 80425-0260-1 |
| NDC Item | 80425026001 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (80425-0260-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 848958 |
| Labeler | Advanced Rx Pharmacy of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 80425-0260 |
NDC Item 80425036601
| NDC 9 | 80425-0366 |
|---|---|
| NDC 10 | 80425-0366-1 |
| NDC Item | 80425036601 |
| Packaging | 5 mL in 1 BOTTLE (80425-0366-1) |
| FDA SPL set id | 847557 |
| Labeler | Advanced Rx of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2023-11-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 80425-0366 |
NDC Item 00574403105
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-05 |
| NDC Item | 00574403105 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (0574-4031-05) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403110
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-10 |
| NDC Item | 00574403110 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (0574-4031-10) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403125
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-25 |
| NDC Item | 00574403125 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (0574-4031-25) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 24208029505
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-05 |
| NDC Item | 24208029505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029510
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-10 |
| NDC Item | 24208029510 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-10) / 10 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029525
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-25 |
| NDC Item | 24208029525 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-25) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 50090113500
| NDC 9 | 50090-1135 |
|---|---|
| NDC 10 | 50090-1135-0 |
| NDC Item | 50090113500 |
| Packaging | 2.5 mL in 1 BOTTLE (50090-1135-0) |
| FDA SPL set id | 718677 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1135 |
NDC Item 50090113600
| NDC 9 | 50090-1136 |
|---|---|
| NDC 10 | 50090-1136-0 |
| NDC Item | 50090113600 |
| Packaging | 5 mL in 1 BOTTLE (50090-1136-0) |
| FDA SPL set id | 803024 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1136 |
NDC Item 50090189300
| NDC 9 | 50090-1893 |
|---|---|
| NDC 10 | 50090-1893-0 |
| NDC Item | 50090189300 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1893-0) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 771442 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1893 |
NDC Item 50090191400
| NDC 9 | 50090-1914 |
|---|---|
| NDC 10 | 50090-1914-0 |
| NDC Item | 50090191400 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1914-0) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 693387 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1914 |
NDC Item 50090726700
| NDC 9 | 50090-7267 |
|---|---|
| NDC 10 | 50090-7267-0 |
| NDC Item | 50090726700 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (50090-7267-0) |
| ANDA | ANDA212715 |
| FDA SPL set id | 817223 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-7267 |
NDC Item 52959098401
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-01 |
| NDC Item | 52959098401 |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 52959098410
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-10 |
| NDC Item | 52959098410 |
| Packaging | 10 mL in 1 BOTTLE (52959-984-10) |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 55700091505
| NDC 9 | 55700-915 |
|---|---|
| NDC 10 | 55700-915-05 |
| NDC Item | 55700091505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (55700-915-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 653524 |
| Labeler | Quality Care Products, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55700-915 |
NDC Item 61314064705
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-05 |
| NDC Item | 61314064705 |
| Packaging | 5 mL in 1 BOTTLE (61314-647-05) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064710
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-10 |
| NDC Item | 61314064710 |
| Packaging | 10 mL in 1 BOTTLE (61314-647-10) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064725
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-25 |
| NDC Item | 61314064725 |
| Packaging | 2.5 mL in 1 BOTTLE (61314-647-25) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 63629957001
| NDC 9 | 63629-9570 |
|---|---|
| NDC 10 | 63629-9570-1 |
| NDC Item | 63629957001 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (63629-9570-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763323 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9570 |
NDC Item 63629957101
| NDC 9 | 63629-9571 |
|---|---|
| NDC 10 | 63629-9571-1 |
| NDC Item | 63629957101 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (63629-9571-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763569 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9571 |
NDC Item 63629957201
| NDC 9 | 63629-9572 |
|---|---|
| NDC 10 | 63629-9572-1 |
| NDC Item | 63629957201 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (63629-9572-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763269 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9572 |
NDC Item 67296066501
| NDC 9 | 67296-0665 |
|---|---|
| NDC 10 | 67296-0665-1 |
| NDC Item | 67296066501 |
| Packaging | 5 mL in 1 BOTTLE (67296-0665-1) |
| FDA SPL set id | 813479 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 67296-0665 |
NDC Item 68071182102
| NDC 9 | 68071-1821 |
|---|---|
| NDC 10 | 68071-1821-2 |
| NDC Item | 68071182102 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (68071-1821-2) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 858986 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-1821 |
NDC Item 68071420305
| NDC 9 | 68071-4203 |
|---|---|
| NDC 10 | 68071-4203-5 |
| NDC Item | 68071420305 |
| Packaging | 5 mL in 1 BOX (68071-4203-5) |
| ANDA | ANDA064134 |
| FDA SPL set id | 790175 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-4203 |
NDC Item 69238137302
| NDC 9 | 69238-1373 |
|---|---|
| NDC 10 | 69238-1373-2 |
| NDC Item | 69238137302 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1373-2) / 2.5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1373 |
NDC Item 69238137403
| NDC 9 | 69238-1374 |
|---|---|
| NDC 10 | 69238-1374-3 |
| NDC Item | 69238137403 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1374-3) / 5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1374 |
NDC Item 69238137506
| NDC 9 | 69238-1375 |
|---|---|
| NDC 10 | 69238-1375-6 |
| NDC Item | 69238137506 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1375-6) / 10 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1375 |
NDC Item 70518399400
| NDC 9 | 70518-3994 |
|---|---|
| NDC 10 | 70518-3994-0 |
| NDC Item | 70518399400 |
| Packaging | 5 mL in 1 BOTTLE (70518-3994-0) |
| FDA SPL set id | 766955 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2024-01-24 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 70518-3994 |
NDC Item 72162112802
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-2 |
| NDC Item | 72162112802 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (72162-1128-2) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112804
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-4 |
| NDC Item | 72162112804 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (72162-1128-4) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112807
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-7 |
| NDC Item | 72162112807 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (72162-1128-7) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 80425026001
| NDC 9 | 80425-0260 |
|---|---|
| NDC 10 | 80425-0260-1 |
| NDC Item | 80425026001 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (80425-0260-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 848958 |
| Labeler | Advanced Rx Pharmacy of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 80425-0260 |
NDC Item 80425036601
| NDC 9 | 80425-0366 |
|---|---|
| NDC 10 | 80425-0366-1 |
| NDC Item | 80425036601 |
| Packaging | 5 mL in 1 BOTTLE (80425-0366-1) |
| FDA SPL set id | 847557 |
| Labeler | Advanced Rx of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2023-11-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 80425-0366 |
NDC Item 00574403105
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-05 |
| NDC Item | 00574403105 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (0574-4031-05) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403110
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-10 |
| NDC Item | 00574403110 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (0574-4031-10) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403125
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-25 |
| NDC Item | 00574403125 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (0574-4031-25) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 24208029505
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-05 |
| NDC Item | 24208029505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029510
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-10 |
| NDC Item | 24208029510 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-10) / 10 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029525
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-25 |
| NDC Item | 24208029525 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-25) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 50090113500
| NDC 9 | 50090-1135 |
|---|---|
| NDC 10 | 50090-1135-0 |
| NDC Item | 50090113500 |
| Packaging | 2.5 mL in 1 BOTTLE (50090-1135-0) |
| FDA SPL set id | 718677 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1135 |
NDC Item 50090113600
| NDC 9 | 50090-1136 |
|---|---|
| NDC 10 | 50090-1136-0 |
| NDC Item | 50090113600 |
| Packaging | 5 mL in 1 BOTTLE (50090-1136-0) |
| FDA SPL set id | 803024 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1136 |
NDC Item 50090189300
| NDC 9 | 50090-1893 |
|---|---|
| NDC 10 | 50090-1893-0 |
| NDC Item | 50090189300 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1893-0) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 771442 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1893 |
NDC Item 50090191400
| NDC 9 | 50090-1914 |
|---|---|
| NDC 10 | 50090-1914-0 |
| NDC Item | 50090191400 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1914-0) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 693387 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1914 |
NDC Item 50090726700
| NDC 9 | 50090-7267 |
|---|---|
| NDC 10 | 50090-7267-0 |
| NDC Item | 50090726700 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (50090-7267-0) |
| ANDA | ANDA212715 |
| FDA SPL set id | 817223 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-7267 |
NDC Item 52959098401
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-01 |
| NDC Item | 52959098401 |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 52959098410
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-10 |
| NDC Item | 52959098410 |
| Packaging | 10 mL in 1 BOTTLE (52959-984-10) |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 55700091505
| NDC 9 | 55700-915 |
|---|---|
| NDC 10 | 55700-915-05 |
| NDC Item | 55700091505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (55700-915-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 653524 |
| Labeler | Quality Care Products, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55700-915 |
NDC Item 61314064705
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-05 |
| NDC Item | 61314064705 |
| Packaging | 5 mL in 1 BOTTLE (61314-647-05) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064710
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-10 |
| NDC Item | 61314064710 |
| Packaging | 10 mL in 1 BOTTLE (61314-647-10) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064725
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-25 |
| NDC Item | 61314064725 |
| Packaging | 2.5 mL in 1 BOTTLE (61314-647-25) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 63629957001
| NDC 9 | 63629-9570 |
|---|---|
| NDC 10 | 63629-9570-1 |
| NDC Item | 63629957001 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (63629-9570-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763323 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9570 |
NDC Item 63629957101
| NDC 9 | 63629-9571 |
|---|---|
| NDC 10 | 63629-9571-1 |
| NDC Item | 63629957101 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (63629-9571-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763569 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9571 |
NDC Item 63629957201
| NDC 9 | 63629-9572 |
|---|---|
| NDC 10 | 63629-9572-1 |
| NDC Item | 63629957201 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (63629-9572-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763269 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9572 |
NDC Item 67296066501
| NDC 9 | 67296-0665 |
|---|---|
| NDC 10 | 67296-0665-1 |
| NDC Item | 67296066501 |
| Packaging | 5 mL in 1 BOTTLE (67296-0665-1) |
| FDA SPL set id | 813479 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 67296-0665 |
NDC Item 68071182102
| NDC 9 | 68071-1821 |
|---|---|
| NDC 10 | 68071-1821-2 |
| NDC Item | 68071182102 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (68071-1821-2) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 858986 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-1821 |
NDC Item 68071420305
| NDC 9 | 68071-4203 |
|---|---|
| NDC 10 | 68071-4203-5 |
| NDC Item | 68071420305 |
| Packaging | 5 mL in 1 BOX (68071-4203-5) |
| ANDA | ANDA064134 |
| FDA SPL set id | 790175 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-4203 |
NDC Item 69238137302
| NDC 9 | 69238-1373 |
|---|---|
| NDC 10 | 69238-1373-2 |
| NDC Item | 69238137302 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1373-2) / 2.5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1373 |
NDC Item 69238137403
| NDC 9 | 69238-1374 |
|---|---|
| NDC 10 | 69238-1374-3 |
| NDC Item | 69238137403 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1374-3) / 5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1374 |
NDC Item 69238137506
| NDC 9 | 69238-1375 |
|---|---|
| NDC 10 | 69238-1375-6 |
| NDC Item | 69238137506 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1375-6) / 10 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1375 |
NDC Item 70518399400
| NDC 9 | 70518-3994 |
|---|---|
| NDC 10 | 70518-3994-0 |
| NDC Item | 70518399400 |
| Packaging | 5 mL in 1 BOTTLE (70518-3994-0) |
| FDA SPL set id | 766955 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2024-01-24 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 70518-3994 |
NDC Item 72162112802
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-2 |
| NDC Item | 72162112802 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (72162-1128-2) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112804
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-4 |
| NDC Item | 72162112804 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (72162-1128-4) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112807
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-7 |
| NDC Item | 72162112807 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (72162-1128-7) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 80425026001
| NDC 9 | 80425-0260 |
|---|---|
| NDC 10 | 80425-0260-1 |
| NDC Item | 80425026001 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (80425-0260-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 848958 |
| Labeler | Advanced Rx Pharmacy of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 80425-0260 |
NDC Item 80425036601
| NDC 9 | 80425-0366 |
|---|---|
| NDC 10 | 80425-0366-1 |
| NDC Item | 80425036601 |
| Packaging | 5 mL in 1 BOTTLE (80425-0366-1) |
| FDA SPL set id | 847557 |
| Labeler | Advanced Rx of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2023-11-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 80425-0366 |
NDC Item 00574403105
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-05 |
| NDC Item | 00574403105 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (0574-4031-05) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403110
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-10 |
| NDC Item | 00574403110 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (0574-4031-10) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403125
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-25 |
| NDC Item | 00574403125 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (0574-4031-25) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 24208029505
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-05 |
| NDC Item | 24208029505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029510
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-10 |
| NDC Item | 24208029510 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-10) / 10 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029525
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-25 |
| NDC Item | 24208029525 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-25) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 50090113500
| NDC 9 | 50090-1135 |
|---|---|
| NDC 10 | 50090-1135-0 |
| NDC Item | 50090113500 |
| Packaging | 2.5 mL in 1 BOTTLE (50090-1135-0) |
| FDA SPL set id | 718677 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1135 |
NDC Item 50090113600
| NDC 9 | 50090-1136 |
|---|---|
| NDC 10 | 50090-1136-0 |
| NDC Item | 50090113600 |
| Packaging | 5 mL in 1 BOTTLE (50090-1136-0) |
| FDA SPL set id | 803024 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1136 |
NDC Item 50090189300
| NDC 9 | 50090-1893 |
|---|---|
| NDC 10 | 50090-1893-0 |
| NDC Item | 50090189300 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1893-0) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 771442 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1893 |
NDC Item 50090191400
| NDC 9 | 50090-1914 |
|---|---|
| NDC 10 | 50090-1914-0 |
| NDC Item | 50090191400 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1914-0) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 693387 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1914 |
NDC Item 50090726700
| NDC 9 | 50090-7267 |
|---|---|
| NDC 10 | 50090-7267-0 |
| NDC Item | 50090726700 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (50090-7267-0) |
| ANDA | ANDA212715 |
| FDA SPL set id | 817223 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-7267 |
NDC Item 52959098401
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-01 |
| NDC Item | 52959098401 |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 52959098410
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-10 |
| NDC Item | 52959098410 |
| Packaging | 10 mL in 1 BOTTLE (52959-984-10) |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 55700091505
| NDC 9 | 55700-915 |
|---|---|
| NDC 10 | 55700-915-05 |
| NDC Item | 55700091505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (55700-915-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 653524 |
| Labeler | Quality Care Products, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55700-915 |
NDC Item 61314064705
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-05 |
| NDC Item | 61314064705 |
| Packaging | 5 mL in 1 BOTTLE (61314-647-05) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064710
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-10 |
| NDC Item | 61314064710 |
| Packaging | 10 mL in 1 BOTTLE (61314-647-10) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064725
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-25 |
| NDC Item | 61314064725 |
| Packaging | 2.5 mL in 1 BOTTLE (61314-647-25) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 63629957001
| NDC 9 | 63629-9570 |
|---|---|
| NDC 10 | 63629-9570-1 |
| NDC Item | 63629957001 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (63629-9570-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763323 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9570 |
NDC Item 63629957101
| NDC 9 | 63629-9571 |
|---|---|
| NDC 10 | 63629-9571-1 |
| NDC Item | 63629957101 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (63629-9571-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763569 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9571 |
NDC Item 63629957201
| NDC 9 | 63629-9572 |
|---|---|
| NDC 10 | 63629-9572-1 |
| NDC Item | 63629957201 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (63629-9572-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763269 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9572 |
NDC Item 67296066501
| NDC 9 | 67296-0665 |
|---|---|
| NDC 10 | 67296-0665-1 |
| NDC Item | 67296066501 |
| Packaging | 5 mL in 1 BOTTLE (67296-0665-1) |
| FDA SPL set id | 813479 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 67296-0665 |
NDC Item 68071182102
| NDC 9 | 68071-1821 |
|---|---|
| NDC 10 | 68071-1821-2 |
| NDC Item | 68071182102 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (68071-1821-2) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 858986 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-1821 |
NDC Item 68071420305
| NDC 9 | 68071-4203 |
|---|---|
| NDC 10 | 68071-4203-5 |
| NDC Item | 68071420305 |
| Packaging | 5 mL in 1 BOX (68071-4203-5) |
| ANDA | ANDA064134 |
| FDA SPL set id | 790175 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-4203 |
NDC Item 69238137302
| NDC 9 | 69238-1373 |
|---|---|
| NDC 10 | 69238-1373-2 |
| NDC Item | 69238137302 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1373-2) / 2.5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1373 |
NDC Item 69238137403
| NDC 9 | 69238-1374 |
|---|---|
| NDC 10 | 69238-1374-3 |
| NDC Item | 69238137403 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1374-3) / 5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1374 |
NDC Item 69238137506
| NDC 9 | 69238-1375 |
|---|---|
| NDC 10 | 69238-1375-6 |
| NDC Item | 69238137506 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1375-6) / 10 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1375 |
NDC Item 70518399400
| NDC 9 | 70518-3994 |
|---|---|
| NDC 10 | 70518-3994-0 |
| NDC Item | 70518399400 |
| Packaging | 5 mL in 1 BOTTLE (70518-3994-0) |
| FDA SPL set id | 766955 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2024-01-24 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 70518-3994 |
NDC Item 72162112802
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-2 |
| NDC Item | 72162112802 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (72162-1128-2) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112804
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-4 |
| NDC Item | 72162112804 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (72162-1128-4) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112807
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-7 |
| NDC Item | 72162112807 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (72162-1128-7) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 80425026001
| NDC 9 | 80425-0260 |
|---|---|
| NDC 10 | 80425-0260-1 |
| NDC Item | 80425026001 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (80425-0260-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 848958 |
| Labeler | Advanced Rx Pharmacy of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 80425-0260 |
NDC Item 80425036601
| NDC 9 | 80425-0366 |
|---|---|
| NDC 10 | 80425-0366-1 |
| NDC Item | 80425036601 |
| Packaging | 5 mL in 1 BOTTLE (80425-0366-1) |
| FDA SPL set id | 847557 |
| Labeler | Advanced Rx of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2023-11-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 80425-0366 |
NDC Item 00574403105
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-05 |
| NDC Item | 00574403105 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (0574-4031-05) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403110
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-10 |
| NDC Item | 00574403110 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (0574-4031-10) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403125
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-25 |
| NDC Item | 00574403125 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (0574-4031-25) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 24208029505
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-05 |
| NDC Item | 24208029505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029510
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-10 |
| NDC Item | 24208029510 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-10) / 10 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029525
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-25 |
| NDC Item | 24208029525 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-25) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 50090113500
| NDC 9 | 50090-1135 |
|---|---|
| NDC 10 | 50090-1135-0 |
| NDC Item | 50090113500 |
| Packaging | 2.5 mL in 1 BOTTLE (50090-1135-0) |
| FDA SPL set id | 718677 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1135 |
NDC Item 50090113600
| NDC 9 | 50090-1136 |
|---|---|
| NDC 10 | 50090-1136-0 |
| NDC Item | 50090113600 |
| Packaging | 5 mL in 1 BOTTLE (50090-1136-0) |
| FDA SPL set id | 803024 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1136 |
NDC Item 50090189300
| NDC 9 | 50090-1893 |
|---|---|
| NDC 10 | 50090-1893-0 |
| NDC Item | 50090189300 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1893-0) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 771442 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1893 |
NDC Item 50090191400
| NDC 9 | 50090-1914 |
|---|---|
| NDC 10 | 50090-1914-0 |
| NDC Item | 50090191400 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1914-0) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 693387 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1914 |
NDC Item 50090726700
| NDC 9 | 50090-7267 |
|---|---|
| NDC 10 | 50090-7267-0 |
| NDC Item | 50090726700 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (50090-7267-0) |
| ANDA | ANDA212715 |
| FDA SPL set id | 817223 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-7267 |
NDC Item 52959098401
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-01 |
| NDC Item | 52959098401 |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 52959098410
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-10 |
| NDC Item | 52959098410 |
| Packaging | 10 mL in 1 BOTTLE (52959-984-10) |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 55700091505
| NDC 9 | 55700-915 |
|---|---|
| NDC 10 | 55700-915-05 |
| NDC Item | 55700091505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (55700-915-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 653524 |
| Labeler | Quality Care Products, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55700-915 |
NDC Item 61314064705
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-05 |
| NDC Item | 61314064705 |
| Packaging | 5 mL in 1 BOTTLE (61314-647-05) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064710
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-10 |
| NDC Item | 61314064710 |
| Packaging | 10 mL in 1 BOTTLE (61314-647-10) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064725
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-25 |
| NDC Item | 61314064725 |
| Packaging | 2.5 mL in 1 BOTTLE (61314-647-25) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 63629957001
| NDC 9 | 63629-9570 |
|---|---|
| NDC 10 | 63629-9570-1 |
| NDC Item | 63629957001 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (63629-9570-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763323 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9570 |
NDC Item 63629957101
| NDC 9 | 63629-9571 |
|---|---|
| NDC 10 | 63629-9571-1 |
| NDC Item | 63629957101 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (63629-9571-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763569 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9571 |
NDC Item 63629957201
| NDC 9 | 63629-9572 |
|---|---|
| NDC 10 | 63629-9572-1 |
| NDC Item | 63629957201 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (63629-9572-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763269 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9572 |
NDC Item 67296066501
| NDC 9 | 67296-0665 |
|---|---|
| NDC 10 | 67296-0665-1 |
| NDC Item | 67296066501 |
| Packaging | 5 mL in 1 BOTTLE (67296-0665-1) |
| FDA SPL set id | 813479 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 67296-0665 |
NDC Item 68071182102
| NDC 9 | 68071-1821 |
|---|---|
| NDC 10 | 68071-1821-2 |
| NDC Item | 68071182102 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (68071-1821-2) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 858986 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-1821 |
NDC Item 68071420305
| NDC 9 | 68071-4203 |
|---|---|
| NDC 10 | 68071-4203-5 |
| NDC Item | 68071420305 |
| Packaging | 5 mL in 1 BOX (68071-4203-5) |
| ANDA | ANDA064134 |
| FDA SPL set id | 790175 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-4203 |
NDC Item 69238137302
| NDC 9 | 69238-1373 |
|---|---|
| NDC 10 | 69238-1373-2 |
| NDC Item | 69238137302 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1373-2) / 2.5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1373 |
NDC Item 69238137403
| NDC 9 | 69238-1374 |
|---|---|
| NDC 10 | 69238-1374-3 |
| NDC Item | 69238137403 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1374-3) / 5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1374 |
NDC Item 69238137506
| NDC 9 | 69238-1375 |
|---|---|
| NDC 10 | 69238-1375-6 |
| NDC Item | 69238137506 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1375-6) / 10 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1375 |
NDC Item 70518399400
| NDC 9 | 70518-3994 |
|---|---|
| NDC 10 | 70518-3994-0 |
| NDC Item | 70518399400 |
| Packaging | 5 mL in 1 BOTTLE (70518-3994-0) |
| FDA SPL set id | 766955 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2024-01-24 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 70518-3994 |
NDC Item 72162112802
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-2 |
| NDC Item | 72162112802 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (72162-1128-2) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112804
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-4 |
| NDC Item | 72162112804 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (72162-1128-4) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112807
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-7 |
| NDC Item | 72162112807 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (72162-1128-7) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 80425026001
| NDC 9 | 80425-0260 |
|---|---|
| NDC 10 | 80425-0260-1 |
| NDC Item | 80425026001 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (80425-0260-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 848958 |
| Labeler | Advanced Rx Pharmacy of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 80425-0260 |
NDC Item 80425036601
| NDC 9 | 80425-0366 |
|---|---|
| NDC 10 | 80425-0366-1 |
| NDC Item | 80425036601 |
| Packaging | 5 mL in 1 BOTTLE (80425-0366-1) |
| FDA SPL set id | 847557 |
| Labeler | Advanced Rx of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2023-11-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 80425-0366 |
NDC Item 00574403105
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-05 |
| NDC Item | 00574403105 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (0574-4031-05) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403110
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-10 |
| NDC Item | 00574403110 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (0574-4031-10) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403125
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-25 |
| NDC Item | 00574403125 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (0574-4031-25) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 24208029505
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-05 |
| NDC Item | 24208029505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029510
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-10 |
| NDC Item | 24208029510 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-10) / 10 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029525
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-25 |
| NDC Item | 24208029525 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-25) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 50090113500
| NDC 9 | 50090-1135 |
|---|---|
| NDC 10 | 50090-1135-0 |
| NDC Item | 50090113500 |
| Packaging | 2.5 mL in 1 BOTTLE (50090-1135-0) |
| FDA SPL set id | 718677 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1135 |
NDC Item 50090113600
| NDC 9 | 50090-1136 |
|---|---|
| NDC 10 | 50090-1136-0 |
| NDC Item | 50090113600 |
| Packaging | 5 mL in 1 BOTTLE (50090-1136-0) |
| FDA SPL set id | 803024 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1136 |
NDC Item 50090189300
| NDC 9 | 50090-1893 |
|---|---|
| NDC 10 | 50090-1893-0 |
| NDC Item | 50090189300 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1893-0) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 771442 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1893 |
NDC Item 50090191400
| NDC 9 | 50090-1914 |
|---|---|
| NDC 10 | 50090-1914-0 |
| NDC Item | 50090191400 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1914-0) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 693387 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1914 |
NDC Item 50090726700
| NDC 9 | 50090-7267 |
|---|---|
| NDC 10 | 50090-7267-0 |
| NDC Item | 50090726700 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (50090-7267-0) |
| ANDA | ANDA212715 |
| FDA SPL set id | 817223 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-7267 |
NDC Item 52959098401
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-01 |
| NDC Item | 52959098401 |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 52959098410
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-10 |
| NDC Item | 52959098410 |
| Packaging | 10 mL in 1 BOTTLE (52959-984-10) |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 55700091505
| NDC 9 | 55700-915 |
|---|---|
| NDC 10 | 55700-915-05 |
| NDC Item | 55700091505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (55700-915-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 653524 |
| Labeler | Quality Care Products, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55700-915 |
NDC Item 61314064705
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-05 |
| NDC Item | 61314064705 |
| Packaging | 5 mL in 1 BOTTLE (61314-647-05) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064710
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-10 |
| NDC Item | 61314064710 |
| Packaging | 10 mL in 1 BOTTLE (61314-647-10) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064725
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-25 |
| NDC Item | 61314064725 |
| Packaging | 2.5 mL in 1 BOTTLE (61314-647-25) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 63629957001
| NDC 9 | 63629-9570 |
|---|---|
| NDC 10 | 63629-9570-1 |
| NDC Item | 63629957001 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (63629-9570-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763323 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9570 |
NDC Item 63629957101
| NDC 9 | 63629-9571 |
|---|---|
| NDC 10 | 63629-9571-1 |
| NDC Item | 63629957101 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (63629-9571-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763569 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9571 |
NDC Item 63629957201
| NDC 9 | 63629-9572 |
|---|---|
| NDC 10 | 63629-9572-1 |
| NDC Item | 63629957201 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (63629-9572-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763269 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9572 |
NDC Item 67296066501
| NDC 9 | 67296-0665 |
|---|---|
| NDC 10 | 67296-0665-1 |
| NDC Item | 67296066501 |
| Packaging | 5 mL in 1 BOTTLE (67296-0665-1) |
| FDA SPL set id | 813479 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 67296-0665 |
NDC Item 68071182102
| NDC 9 | 68071-1821 |
|---|---|
| NDC 10 | 68071-1821-2 |
| NDC Item | 68071182102 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (68071-1821-2) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 858986 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-1821 |
NDC Item 68071420305
| NDC 9 | 68071-4203 |
|---|---|
| NDC 10 | 68071-4203-5 |
| NDC Item | 68071420305 |
| Packaging | 5 mL in 1 BOX (68071-4203-5) |
| ANDA | ANDA064134 |
| FDA SPL set id | 790175 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-4203 |
NDC Item 69238137302
| NDC 9 | 69238-1373 |
|---|---|
| NDC 10 | 69238-1373-2 |
| NDC Item | 69238137302 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1373-2) / 2.5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1373 |
NDC Item 69238137403
| NDC 9 | 69238-1374 |
|---|---|
| NDC 10 | 69238-1374-3 |
| NDC Item | 69238137403 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1374-3) / 5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1374 |
NDC Item 69238137506
| NDC 9 | 69238-1375 |
|---|---|
| NDC 10 | 69238-1375-6 |
| NDC Item | 69238137506 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1375-6) / 10 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1375 |
NDC Item 70518399400
| NDC 9 | 70518-3994 |
|---|---|
| NDC 10 | 70518-3994-0 |
| NDC Item | 70518399400 |
| Packaging | 5 mL in 1 BOTTLE (70518-3994-0) |
| FDA SPL set id | 766955 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2024-01-24 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 70518-3994 |
NDC Item 72162112802
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-2 |
| NDC Item | 72162112802 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (72162-1128-2) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112804
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-4 |
| NDC Item | 72162112804 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (72162-1128-4) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112807
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-7 |
| NDC Item | 72162112807 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (72162-1128-7) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 80425026001
| NDC 9 | 80425-0260 |
|---|---|
| NDC 10 | 80425-0260-1 |
| NDC Item | 80425026001 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (80425-0260-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 848958 |
| Labeler | Advanced Rx Pharmacy of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 80425-0260 |
NDC Item 80425036601
| NDC 9 | 80425-0366 |
|---|---|
| NDC 10 | 80425-0366-1 |
| NDC Item | 80425036601 |
| Packaging | 5 mL in 1 BOTTLE (80425-0366-1) |
| FDA SPL set id | 847557 |
| Labeler | Advanced Rx of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2023-11-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 80425-0366 |
NDC Item 00574403105
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-05 |
| NDC Item | 00574403105 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (0574-4031-05) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403110
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-10 |
| NDC Item | 00574403110 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (0574-4031-10) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403125
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-25 |
| NDC Item | 00574403125 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (0574-4031-25) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 24208029505
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-05 |
| NDC Item | 24208029505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029510
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-10 |
| NDC Item | 24208029510 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-10) / 10 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029525
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-25 |
| NDC Item | 24208029525 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-25) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 50090113500
| NDC 9 | 50090-1135 |
|---|---|
| NDC 10 | 50090-1135-0 |
| NDC Item | 50090113500 |
| Packaging | 2.5 mL in 1 BOTTLE (50090-1135-0) |
| FDA SPL set id | 718677 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1135 |
NDC Item 50090113600
| NDC 9 | 50090-1136 |
|---|---|
| NDC 10 | 50090-1136-0 |
| NDC Item | 50090113600 |
| Packaging | 5 mL in 1 BOTTLE (50090-1136-0) |
| FDA SPL set id | 803024 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1136 |
NDC Item 50090189300
| NDC 9 | 50090-1893 |
|---|---|
| NDC 10 | 50090-1893-0 |
| NDC Item | 50090189300 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1893-0) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 771442 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1893 |
NDC Item 50090191400
| NDC 9 | 50090-1914 |
|---|---|
| NDC 10 | 50090-1914-0 |
| NDC Item | 50090191400 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1914-0) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 693387 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1914 |
NDC Item 50090726700
| NDC 9 | 50090-7267 |
|---|---|
| NDC 10 | 50090-7267-0 |
| NDC Item | 50090726700 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (50090-7267-0) |
| ANDA | ANDA212715 |
| FDA SPL set id | 817223 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-7267 |
NDC Item 52959098401
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-01 |
| NDC Item | 52959098401 |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 52959098410
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-10 |
| NDC Item | 52959098410 |
| Packaging | 10 mL in 1 BOTTLE (52959-984-10) |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 55700091505
| NDC 9 | 55700-915 |
|---|---|
| NDC 10 | 55700-915-05 |
| NDC Item | 55700091505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (55700-915-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 653524 |
| Labeler | Quality Care Products, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55700-915 |
NDC Item 61314064705
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-05 |
| NDC Item | 61314064705 |
| Packaging | 5 mL in 1 BOTTLE (61314-647-05) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064710
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-10 |
| NDC Item | 61314064710 |
| Packaging | 10 mL in 1 BOTTLE (61314-647-10) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064725
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-25 |
| NDC Item | 61314064725 |
| Packaging | 2.5 mL in 1 BOTTLE (61314-647-25) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 63629957001
| NDC 9 | 63629-9570 |
|---|---|
| NDC 10 | 63629-9570-1 |
| NDC Item | 63629957001 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (63629-9570-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763323 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9570 |
NDC Item 63629957101
| NDC 9 | 63629-9571 |
|---|---|
| NDC 10 | 63629-9571-1 |
| NDC Item | 63629957101 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (63629-9571-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763569 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9571 |
NDC Item 63629957201
| NDC 9 | 63629-9572 |
|---|---|
| NDC 10 | 63629-9572-1 |
| NDC Item | 63629957201 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (63629-9572-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763269 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9572 |
NDC Item 67296066501
| NDC 9 | 67296-0665 |
|---|---|
| NDC 10 | 67296-0665-1 |
| NDC Item | 67296066501 |
| Packaging | 5 mL in 1 BOTTLE (67296-0665-1) |
| FDA SPL set id | 813479 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 67296-0665 |
NDC Item 68071182102
| NDC 9 | 68071-1821 |
|---|---|
| NDC 10 | 68071-1821-2 |
| NDC Item | 68071182102 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (68071-1821-2) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 858986 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-1821 |
NDC Item 68071420305
| NDC 9 | 68071-4203 |
|---|---|
| NDC 10 | 68071-4203-5 |
| NDC Item | 68071420305 |
| Packaging | 5 mL in 1 BOX (68071-4203-5) |
| ANDA | ANDA064134 |
| FDA SPL set id | 790175 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-4203 |
NDC Item 69238137302
| NDC 9 | 69238-1373 |
|---|---|
| NDC 10 | 69238-1373-2 |
| NDC Item | 69238137302 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1373-2) / 2.5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1373 |
NDC Item 69238137403
| NDC 9 | 69238-1374 |
|---|---|
| NDC 10 | 69238-1374-3 |
| NDC Item | 69238137403 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1374-3) / 5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1374 |
NDC Item 69238137506
| NDC 9 | 69238-1375 |
|---|---|
| NDC 10 | 69238-1375-6 |
| NDC Item | 69238137506 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1375-6) / 10 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1375 |
NDC Item 70518399400
| NDC 9 | 70518-3994 |
|---|---|
| NDC 10 | 70518-3994-0 |
| NDC Item | 70518399400 |
| Packaging | 5 mL in 1 BOTTLE (70518-3994-0) |
| FDA SPL set id | 766955 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2024-01-24 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 70518-3994 |
NDC Item 72162112802
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-2 |
| NDC Item | 72162112802 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (72162-1128-2) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112804
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-4 |
| NDC Item | 72162112804 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (72162-1128-4) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112807
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-7 |
| NDC Item | 72162112807 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (72162-1128-7) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 80425026001
| NDC 9 | 80425-0260 |
|---|---|
| NDC 10 | 80425-0260-1 |
| NDC Item | 80425026001 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (80425-0260-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 848958 |
| Labeler | Advanced Rx Pharmacy of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 80425-0260 |
NDC Item 80425036601
| NDC 9 | 80425-0366 |
|---|---|
| NDC 10 | 80425-0366-1 |
| NDC Item | 80425036601 |
| Packaging | 5 mL in 1 BOTTLE (80425-0366-1) |
| FDA SPL set id | 847557 |
| Labeler | Advanced Rx of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2023-11-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 80425-0366 |
NDC Item 00574403105
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-05 |
| NDC Item | 00574403105 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (0574-4031-05) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403110
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-10 |
| NDC Item | 00574403110 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (0574-4031-10) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 00574403125
| NDC 9 | 0574-4031 |
|---|---|
| NDC 10 | 0574-4031-25 |
| NDC Item | 00574403125 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (0574-4031-25) |
| ANDA | ANDA212715 |
| FDA SPL set id | 777631 |
| Labeler | Padagis US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0574-4031 |
NDC Item 24208029505
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-05 |
| NDC Item | 24208029505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029510
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-10 |
| NDC Item | 24208029510 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-10) / 10 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 24208029525
| NDC 9 | 24208-295 |
|---|---|
| NDC 10 | 24208-295-25 |
| NDC Item | 24208029525 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-25) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 736214 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24208-295 |
NDC Item 50090113500
| NDC 9 | 50090-1135 |
|---|---|
| NDC 10 | 50090-1135-0 |
| NDC Item | 50090113500 |
| Packaging | 2.5 mL in 1 BOTTLE (50090-1135-0) |
| FDA SPL set id | 718677 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1135 |
NDC Item 50090113600
| NDC 9 | 50090-1136 |
|---|---|
| NDC 10 | 50090-1136-0 |
| NDC Item | 50090113600 |
| Packaging | 5 mL in 1 BOTTLE (50090-1136-0) |
| FDA SPL set id | 803024 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 50090-1136 |
NDC Item 50090189300
| NDC 9 | 50090-1893 |
|---|---|
| NDC 10 | 50090-1893-0 |
| NDC Item | 50090189300 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1893-0) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 771442 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1893 |
NDC Item 50090191400
| NDC 9 | 50090-1914 |
|---|---|
| NDC 10 | 50090-1914-0 |
| NDC Item | 50090191400 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (50090-1914-0) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 693387 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-1914 |
NDC Item 50090726700
| NDC 9 | 50090-7267 |
|---|---|
| NDC 10 | 50090-7267-0 |
| NDC Item | 50090726700 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (50090-7267-0) |
| ANDA | ANDA212715 |
| FDA SPL set id | 817223 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-7267 |
NDC Item 52959098401
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-01 |
| NDC Item | 52959098401 |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 52959098410
| NDC 9 | 52959-984 |
|---|---|
| NDC 10 | 52959-984-10 |
| NDC Item | 52959098410 |
| Packaging | 10 mL in 1 BOTTLE (52959-984-10) |
| FDA SPL set id | 57994 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 52959-984 |
NDC Item 55700091505
| NDC 9 | 55700-915 |
|---|---|
| NDC 10 | 55700-915-05 |
| NDC Item | 55700091505 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (55700-915-05) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 653524 |
| Labeler | Quality Care Products, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55700-915 |
NDC Item 61314064705
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-05 |
| NDC Item | 61314064705 |
| Packaging | 5 mL in 1 BOTTLE (61314-647-05) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064710
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-10 |
| NDC Item | 61314064710 |
| Packaging | 10 mL in 1 BOTTLE (61314-647-10) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 61314064725
| NDC 9 | 61314-647 |
|---|---|
| NDC 10 | 61314-647-25 |
| NDC Item | 61314064725 |
| Packaging | 2.5 mL in 1 BOTTLE (61314-647-25) |
| FDA SPL set id | 871293 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 61314-647 |
NDC Item 63629957001
| NDC 9 | 63629-9570 |
|---|---|
| NDC 10 | 63629-9570-1 |
| NDC Item | 63629957001 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (63629-9570-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763323 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9570 |
NDC Item 63629957101
| NDC 9 | 63629-9571 |
|---|---|
| NDC 10 | 63629-9571-1 |
| NDC Item | 63629957101 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (63629-9571-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763569 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9571 |
NDC Item 63629957201
| NDC 9 | 63629-9572 |
|---|---|
| NDC 10 | 63629-9572-1 |
| NDC Item | 63629957201 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (63629-9572-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 763269 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9572 |
NDC Item 67296066501
| NDC 9 | 67296-0665 |
|---|---|
| NDC 10 | 67296-0665-1 |
| NDC Item | 67296066501 |
| Packaging | 5 mL in 1 BOTTLE (67296-0665-1) |
| FDA SPL set id | 813479 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2009-01-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 67296-0665 |
NDC Item 68071182102
| NDC 9 | 68071-1821 |
|---|---|
| NDC 10 | 68071-1821-2 |
| NDC Item | 68071182102 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (68071-1821-2) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA064134 |
| FDA SPL set id | 858986 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-1821 |
NDC Item 68071420305
| NDC 9 | 68071-4203 |
|---|---|
| NDC 10 | 68071-4203-5 |
| NDC Item | 68071420305 |
| Packaging | 5 mL in 1 BOX (68071-4203-5) |
| ANDA | ANDA064134 |
| FDA SPL set id | 790175 |
| Labeler | NuCare Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1999-10-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68071-4203 |
NDC Item 69238137302
| NDC 9 | 69238-1373 |
|---|---|
| NDC 10 | 69238-1373-2 |
| NDC Item | 69238137302 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1373-2) / 2.5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1373 |
NDC Item 69238137403
| NDC 9 | 69238-1374 |
|---|---|
| NDC 10 | 69238-1374-3 |
| NDC Item | 69238137403 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1374-3) / 5 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1374 |
NDC Item 69238137506
| NDC 9 | 69238-1375 |
|---|---|
| NDC 10 | 69238-1375-6 |
| NDC Item | 69238137506 |
| Packaging | 1 BOTTLE, PLASTIC in 1 CARTON (69238-1375-6) / 10 mL in 1 BOTTLE, PLASTIC |
| ANDA | ANDA212991 |
| COLORTEXT | white(white to off-white uniform suspension) |
| Color | C48325 __ |
| FDA SPL set id | 803363 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69238-1375 |
NDC Item 70518399400
| NDC 9 | 70518-3994 |
|---|---|
| NDC 10 | 70518-3994-0 |
| NDC Item | 70518399400 |
| Packaging | 5 mL in 1 BOTTLE (70518-3994-0) |
| FDA SPL set id | 766955 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2024-01-24 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 70518-3994 |
NDC Item 72162112802
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-2 |
| NDC Item | 72162112802 |
| Packaging | 10 mL in 1 BOTTLE, PLASTIC (72162-1128-2) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112804
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-4 |
| NDC Item | 72162112804 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (72162-1128-4) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 72162112807
| NDC 9 | 72162-1128 |
|---|---|
| NDC 10 | 72162-1128-7 |
| NDC Item | 72162112807 |
| Packaging | 2.5 mL in 1 BOTTLE, PLASTIC (72162-1128-7) |
| ANDA | ANDA212715 |
| FDA SPL set id | 847199 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1128 |
NDC Item 80425026001
| NDC 9 | 80425-0260 |
|---|---|
| NDC 10 | 80425-0260-1 |
| NDC Item | 80425026001 |
| Packaging | 5 mL in 1 BOTTLE, PLASTIC (80425-0260-1) |
| ANDA | ANDA212715 |
| FDA SPL set id | 848958 |
| Labeler | Advanced Rx Pharmacy of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 80425-0260 |
NDC Item 80425036601
| NDC 9 | 80425-0366 |
|---|---|
| NDC 10 | 80425-0366-1 |
| NDC Item | 80425036601 |
| Packaging | 5 mL in 1 BOTTLE (80425-0366-1) |
| FDA SPL set id | 847557 |
| Labeler | Advanced Rx of Tennessee, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2023-11-02 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA050592 |
| Related queries | Properties for NDC 9 80425-0366 |